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mTORC1 activity in vivo through caloric restriction, nutrient stimulation with branched chain amino acids,
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ABSTRACT 
 
THE CELLULAR AND MOLECULAR UNDERPINNINGS OF INTESTINAL EPITHELIAL 
REGENERATION 
Maryam Yousefi 
Christopher J. Lengner 
 
Injury to the intestinal epithelium is a hallmark of numerous common clinical disorders, 
including radiation enteropathy, ischemia-reperfusion, and inflammatory bowel diseases.  
Disruption of the epithelial barrier in these conditions must be quickly restored to avoid 
dehydration and translocation of gut microbiota to the bloodstream. Short-term calorie restriction 
can enhance regenerative response of the intestinal epithelium following DNA damaging injury. 
However, the specific cell type responsible for this enhanced regenerative capacity and as a 
result the molecular determinants of this process remain unknown. 
Regeneration of the intestinal epithelium is driven by multiple intestinal stem cell (ISC) 
types, including an active, radiosensitive Wnthigh ISC that fuels turnover during homeostasis and a 
reserve, radioresistant Wntlow/off ISC capable of generating active Wnthigh ISCs. In this study, I 
utilize mouse genetic approaches to mark, isolate, and ablate intestinal stem cell (ISC) 
populations in order to address, for the first time, the functional importance of reserve ISCs for 
optimal regeneration following DNA damaging injury in response to caloric restriction. I 
demonstrate that modulation of mTORC1 signaling in reserve ISCs is a key factor in the 
regenerative response to radiation injury. I show that mTORC1 is both necessary and sufficient 
for the activation reserve ISCs. Loss of mTORC1 activity in reserve ISCs following injury impairs 
tissue regeneration due to failure of reserve stem cell activation. Conversely, promiscuous 
mTORC1 activation prior to injury sensitizes the epithelium to radiation damage as premature 
activation of reserve ISCs renders them susceptible to the radiation-induced apoptosis.  
I demonstrate that Musashi (Msi) family of RNA-binding proteins are potent upstream 
regulator of mTORC1 signaling and metabolic genes in reserve ISCs and, similar to mTORC1 
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signaling, Msi proteins are necessary for intestinal regeneration despite their dispensability for 
intestinal basal homeostasis. I could modulate mTORC1 activity in vivo through caloric restriction, 
nutrient stimulation with branched chain amino acids, and pharmacological intervention with 
Rapamycin to govern activation of reserve ISCs and their sensitivity to radiation. These findings 
delineate a critical role for Msi-mTORC1 axis in regulating reserve ISC activation and epithelial 
regeneration and inform clinical strategies to protect reserve ISCs from genotoxic insults based 
on nutrient modulation. 
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Hierarchy and Plasticity in the Intestinal Stem Cell Compartment 
 
 
 
 
 
 
 
 
 
 
 
 
	 2	
Introduction 
High-turnover tissues including the blood, skin, testes, and intestinal epithelium lose 
millions of cells daily due to basal turnover associated with tissue function and environmental 
exposure. This tremendous turnover highlights the need for exquisite coordination of self-renewal 
of upstream stem and progenitor cells and downstream production of differentiated effector cells.  
It is becoming increasingly clear that the highest turnover tissues (the intestinal 
epithelium and hematopoietic system) organize their stem cell compartments into a hierarchical 
structure with a slow cycling, long-term, injury-resistant stem cell residing at the top of the 
hierarchy giving rise to an actively cycling stem cell that bears the proliferative burden required for 
tissue function. The benefits of such an organizational structure include the capacity to maintain 
the proliferative output necessary to keep up with the demands of high-turnover tissues using a 
relatively small stem cell pool, the ability to efficiently regenerate the tissue after damage, and the 
maintenance of regenerative capacity throughout the lifetime of the organism through 
preservation of stem cell function. Recent studies have not only revealed the existence of this 
hierarchical stem cell organization, but have also demonstrated considerable plasticity within the 
hierarchy.  
 
Stem cell dynamics in the hematopoietic system  
Hematopoietic stem cells (HSCs) serve as a paradigm for studying adult stem cells. 
HSCs are defined as cells with the ability to self-renew and the potential to give rise to all the 
hematopoietic lineages (Weissman et al., 2001). HSCs are a heterogeneous population with 
subsets of long-term (LT) and short-term (ST) HSCs. LT-HSCs vs ST-HSCs is determined by 
their ability to support hematopoiesis post-transplantation into recipient mice for a lifetime (LT) or 
a few months (ST); however these definitions are arbitrary and subject to change as the field 
progresses.  ST-HSCs further give rise to multipotent progenitor cells (MPPs) that have the 
potential to give rise to all hematopoietic lineages, but lack long-term self-renewal ability as 
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evidenced by their rather limited ability to support hematopoiesis for only a few weeks post-
transplantation. MPPs can further give rise to common myeloid progenitors (CMPs), which 
produce mega-erythroid progenitors (MEPs) and granulocyte-macrophage progenitors (GMPs). 
The latter two are the resources of mature megakaryocytes, erythrocytes, granulocytes, and 
macrophages. On the axis of immune lineages, MPPs can give rise to common lymphoid 
progenitors (CLPs), and the latter further produce T, B, and NK cells (Kostetskii et al., 2005; 
Weissman, 2000). This ‘clonal succession’ model in which a very small number LT-HSCs sitting 
at the apex of the hematopoietic pedigree generate the entire hematopoietic system at any given 
time has been dominant in the field for decades.  However, this model is based on the 
transplantation assay, a non-physiological condition that can be considered highly stressful and 
relies upon a cell’s ability to survive in the circulation and home to the bone marrow. Thus, the 
transplantation assay may better represent a post-injury regenerative scenario rather than a 
readout of homeostatic HSC function. Whether basal (or native) hematopoiesis behaviors follow 
this model has recently been challenged. 
The clonal succession model of hematopoiesis, which mainly describes the behavior of 
transplanted donor cells into highly stressed recipient mice, indicates that LT-HSCs rarely divide 
over a life time and mice can tolerate loss of LT-HSCs for up to 6-months without showing any 
lineage bias (Bernitz et al., 2016; Venkatraman et al., 2013; Wilson et al., 2008). These 
observations suggest that LT-HSCs function only as a back-up or reserve subpopulation on 
shorter-term (6-month) time frames (Haug et al., 2008; Li and Clevers, 2010). Taking an 
alternative approach by employing retrotransposition as a means to uniquely barcode individual 
cells and their lineage (as all cells within a lineage will bear the same transposon tag), 
researchers demonstrated that a pool of long-lived progenitors (at least 40 weeks), rather than 
classically defined LT-HSCs, are the main drivers of basal hematopoiesis during most of 
adulthood (Sun et al., 2014). While additional studies employing independent methodologies will 
be important for developing a clear understanding of native versus post-transplantation 
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hematopoiesis, our understanding of stem cell activity in the intestinal epithelium, is derived 
largely from in vivo lineage tracing in native (non-transplanted) tissue. 
 
Active and reserve stem cells of the intestinal epithelium 
As a result of constant exposure to pathogens and xenobiotics, intestinal epithelial cells have 
a short half-life, and have therefore evolved the ability to rapidly regenerate after damage. This 
ability to regenerate rapidly after injury makes the intestine an excellent model system to study 
tissue homeostasis, regeneration and tumorigenesis. In the intestinal epithelium, the most highly 
proliferative tissue in the body, the existence of a hierarchically organized stem cell compartment 
is becoming increasingly evident (Figure 1.1). Actively proliferating and relatively abundant crypt-
base columnar (CBCs) stem cells exhibit high expression of the canonical Wnt pathway target 
gene Lgr5 and were the first genetically marked intestinal stem cell (ISC) population functionally 
validated to give rise to all cell-types in the intestinal epithelium through lineage tracing 
experiments (Barker et al., 2007). The robust contribution of actively cycling Lgr5+ CBCs to 
intestinal homeostasis has been clearly shown under basal conditions and may be conceptually 
analogous to the pool of active hematopoietic progenitors described above in native 
hematopoiesis (Sun et al., 2014).  Remarkably, however, genetic ablation of Lgr5+ cells with 
diphtheria toxin showed that they are dispensable for intestinal homeostasis under basal 
conditions (Tao et al., 2015; Tian et al., 2011). Consistent with this, Lgr5+ cells, and particularly 
Wnthigh Lgr5high CBCs, like all proliferative cells are quantitatively ablated in response to DNA 
damage, such as high dose gamma-irradiation (Tao et al., 2015; Yan et al., 2012) (Figure 1.2).  
Interestingly, diphtheria toxin ablation of Lgr5+ CBCs shortly after or concomitant with radiation 
injury revealed a requirement for these cells for a robust regenerative response, suggesting that 
post-injury de novo generated Lgr5+ CBCs and/or the small fraction of Lgr5+ cells that survive the 
radiation injury play an important role in epithelial regeneration (Metcalfe et al., 2014).  The 
expendable nature of Lgr5+ CBCs during intestinal homeostasis and the susceptibility of actively 
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cycling CBCs to DNA damaging injury imply the presence of additional epithelial cells capable of 
compensating for CBC loss.  
Concomitant with the identification of Lgr5 as a marker of crypt base columnar stem cells, a 
second population of functionally distinct cells was identified through insertion of a CreER 
reporter into the endogenous Bmi1 locus (Sangiorgi and Capecchi, 2008). These cells are slower 
cycling and less frequent than CBCs and, unlike the CBCs, appear indispensable for epithelial 
maintenance under basal conditions (Sangiorgi and Capecchi, 2008).  Since this initial report, 
numerous additional studies have identified rare cells with shared characteristics of the Bmi1-
CreER-marked cells, including those marked by Hopx-CreER (Li et al., 2014; Takeda et al., 
2011), mTert-CreER (Breault et al., 2008; Montgomery et al., 2011), and likely subpopulations of 
much larger groups of cells marked by more broadly expressed reporter alleles including Krt19-
CreER (Asfaha et al., 2015), Lrig1-CreER (Powell et al., 2012), Axin2-CreER (Li et al., 2016a), 
and Sox9-CreER (Roche et al., 2015). These rare stem cells are often referred to as ‘reserve 
ISCs’ based on their slow cycling relative to CBCs, their resistance to DNA damaging injury, as 
well as their proliferative response and increase in lineage tracing in response to such injury 
(Figure 1.2) (Li et al., 2014, 2016b; Sangiorgi and Capecchi, 2008; Yan et al., 2012). They have 
similarly been referred to as ‘quiescent’ stem cells, although only recently has their residence in 
the quiescent state outside of the cell cycle (G0) been formally demonstrated (Li et al., 2016b; 
Yousefi et al., 2016). They have also been referred to as ‘+4’ cells based on their position above 
the crypt base, although we now appreciate that numerous molecularly and functionally distinct 
cells reside around this position. Curiously, the endogenous mTert, Hopx, and Bmi1 mRNAs are 
non-specifically distributed throughout all cells of the crypt base, and thus the presence of the 
transcripts cannot be taken as evidence of cell identity.  Why CreER reporters in most of these 
instances mark a fairly specific subpopulation of reserve ISCs remains unclear; however it is 
tempting to speculate that because these CreER insertions disrupt native 3’UTR sequences, the 
CreER reporters may mark cells in which these loci are actively transcribed, while distribution of 
endogenous mRNAs may reflect message stabilization and inheritance to daughter cells through 
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activity of the long 3’UTR sequences transcribed from these loci and additional noncoding 
functions of protein coding genes, as has been observed in other stem cell compartments (Crist 
et al., 2012). There are considerable disconnects between cells marked by reporter transgenes, 
endogenous protein, and mRNA for many intestinal stem cell markers, and thus caution must be 
taken when assigning stem cell identity based on mRNA/protein/reporter expression as most 
demonstrations of stem cell activity rely solely on lineage tracing assays conducted with Cre 
recombinase. 
Single cell expression profiling confirmed an overlap in the molecular identity of the majority 
of cells marked by Hopx-CreER and Bmi1-CreER, with the Hopx-CreER+ reserve ISCs being as 
homogenous a population as that marked by Lgr5-CreER, but also one that is molecularly distinct 
from the Lgr5-CreER+ CBCs (Li et al., 2014).  The population marked by Bmi1-CreER largely 
overlaps with that marked by Hopx-CreER, although Bmi1-CreER marks a more heterogeneous 
population, including some presumably differentiated cells within the villi and rare CBCs (Li et al., 
2014). Thus, caution should be exercised when interpreting molecular profiles taken from bulk 
populations, as population heterogeneity may prove misleading. In contrast to CBCs, the reserve 
ISCs have little to no detectable readouts of canonical Wnt pathway activity (e.g., expression of 
Lgr5, Ascl2, Ccnd1, etc.), little expression of genes associated with cellular metabolism and 
proliferation (e.g., H6PD, Myc, Msi1), and higher expression of genes encoding cell cycle 
inhibitors (Cdkn1a) (Li et al., 2014, 2016a; Takeda et al., 2011). In summary, these reserve ISCs, 
including those marked by mTert-CreER, share a number of unique functional properties: 1) they 
appear highly resistant to DNA damage (e.g., chemotherapeutics or 12-15Gy of gamma 
irradiation) (Li et al., 2016b; Montgomery et al., 2011; Tinkum et al., 2015), 2) they are slow 
cycling (Li et al., 2014; Yan et al., 2012), 3) they appear refractory to stimulation of the canonical 
Wnt pathway in vivo (Yan et al., 2012), 4) they routinely give rise to lineages (assessed by crypt-
villus lineage tracing) containing all intestinal cell types, including CBCs (Li et al., 2014; 
Montgomery et al., 2011; Sangiorgi and Capecchi, 2008; Tian et al., 2011; Yan et al., 2012), and 
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5) they are necessary for both epithelial maintenance in the basal state as well as proper 
regeneration after injury (Sangiorgi and Capecchi, 2008). 
 Importantly, numerous groups have independently confirmed that the WntOFF reserve stem 
cells give rise to WntHigh CBCs relatively frequently during homeostasis, both through histological 
lineage tracing techniques and molecular profiling of progeny (Asfaha et al., 2015; Li et al., 2014; 
Montgomery et al., 2011; Sangiorgi and Capecchi, 2008; Tao et al., 2015; Yan et al., 2012).  An 
assessment of daughter cell identity from reserve ISCs done by coupling a Hopx-CreER-Lox-
Stop-Lox-tdTomato lineage tracing with a nuclear H2B-GFP pulse-chase as a measure of cell 
division suggests that upon division, these reserve stem cells produce CBCs (evidenced by high 
Lgr5 and Wnt target gene expression) and additional reserve ISCs at similar frequencies, 
indicating that asymmetric self-renewal/commitment (to CBC identity) divisions may occur (Li et 
al., 2014).  Consistent with this, quantification of clonal exhaustion reveals that CBCs undergo 
exhaustion much more rapidly in comparison to reserve ISCs, the latter exhibiting no clonal 
exhaustion after 6 months, while approximately 2/3 of CBC clones undergo exhaustion over this 
same period (Li et al., 2014).  Thus, the culmination of data from numerous groups supports a 
model in which a long-lived, injury resistant reserve stem cell resides upstream of an active, 
shorter-lived, Wnt-driven crypt base columnar stem cell (Figures 1.1 and 1.2). 
 
Plasticity within the hierarchy 
In addition to these compelling data supporting the existence of a hierarchically structured 
ISC compartment, several recent studies have identified surprising plasticity in the tissue as well, 
in which more committed progeny of CBCs can re-acquire the CBC identity, albeit at very low 
frequency (Buczacki et al., 2013) and in the case of non-physiological injury models (such as 
genetic ablation of specific cell types) (Figure 1.2) (Tetteh et al., 2016). Nonetheless, these 
studies clearly demonstrate plasticity in cell identity exists within the crypt. 
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The first evidence of such plasticity arose from studies of label-retaining cells (LRCs).  DNA 
label retention was originally posited to mark cells undergoing asymmetric partitioning of the 
nascent and parental genomes into distinct daughter cells (originally employing tritiated thymidine 
as the label).  This ‘immortal strand’ hypothesis was posited over 40 years ago to act as a 
mechanism protecting long-lived stem cells (which, theoretically, retain the parental genome) 
against replication-induced mutation (Cairns, 1975; Potten et al., 1978, 2002, 2003).  While this 
hypothesis is elegant, little evidence supports it, and significant evidence opposes it (Kiel et al., 
2007).  Nonetheless, the existence of LRCs within the intestine is clear, but what is less clear is 
the identity and function of intestinal LRCs. Since the original tritiated thymidine pulse-chase 
experiments, fusion proteins between fluorophores and histone H2B have become the favored 
tool for identifying LRCs, as H2B fusions enable prospective identification and isolation of living 
cells for molecular profiling and functional assays.  The LRC assay is now used as a means to 
identify non-dividing cells, with the caveat that truly non-dividing cells would be unable to 
incorporate the label because the label can only be incorporated during S-phase.  Thus LRC 
labeling is usually performed by pulsing after injury or early during development, when a 
presumptive dormant stem cell is actively dividing prior to reentering/entering dormancy (Potten 
et al., 2002). 
Curiously, the first study to test the functionality of LRCs in the intestine incorporated the 
label not after injury or in an immature animal, but during a relatively short pulse in a mature 
animal (Buczacki et al., 2013).  This suggests that the LRCs identified by this method represent 
cells undergoing cell cycle exit downstream of a proliferative cell rather than a dormant stem cell 
population.  Indeed, it is now broadly appreciated that long-term (one month chase or longer) 
LRCs of the intestine are in fact a homogenous population of terminally differentiated Paneth cells 
downstream of the CBCs (Buczacki et al., 2013; Li et al., 2016c; Potten et al., 2002; Roth et al., 
2012).  These long-term LRCs are restricted to the small intestine, consistent with the absence of 
Paneth cells in the colon.  Perhaps more interesting was the population of LRCs found after 
shorter-term (8-12 days) chase.  These cells reside at or near the crypt base, and unlike long-
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term LRCs, single cell profiling reveals this population to be highly heterogeneous, including cells 
with gene expression signatures consistent with Paneth cells, enteroendocrine cells, as well as 
rare cells with reserve ISC molecular identity (Buczacki et al., 2013; Li et al., 2016c).  Indeed, 
compound reporter mice, where Hopx-CreER marks reserve ISCs and H2B-GFP marks label 
retaining cells, reveals only a very small fraction of double-positive cells (i.e. label retaining 
reserve ISCs) (Li et al., 2016b). Employing an inducible H2B-Split-Cre system to enable in vivo 
lineage tracing from LRCs demonstrated extremely rare tracing events, particularly in response to 
injury, consistent with the presence of very rare cells with reserve ISC identity within this short-
term LRC population (Buczacki et al., 2013; Li et al., 2016b). Interestingly, short-term LRCs that 
exhibit hallmarks of Paneth or enteroendocrine cell identity retain the ability to form small 
intestinal organoids in vitro, albeit at significantly lower efficiencies than purified populations of 
reserve ISCs (Buczacki et al., 2013; Li et al., 2016c).  When the label retention chase is extended 
to one month, LRCs are no longer able to form organoids.  
Interestingly, the functional and molecular properties of short-term label-retaining secretory 
progenitor cells are shared with cells marked by a Dll1-CreER allele (van Es et al., 2012a).  
These Dll1-CreER-marked cells are the progeny of CBCs, normally generate cells of the 
secretory lineage, form organoids in vitro in the presence of Wnt3a (which is not required for 
organoid formation from CBCs or reserve ISCs), and exhibit very rare lineage tracing activity in 
response to mid-dose radiation injury (6Gy gamma-IR).  Taken together, these findings support a 
model where CBCs activate Dll1 as they enter the secretory lineage (in opposition to the transit-
amplifying enterocyte lineage, Figure 1.3) and shortly thereafter exit the cell cycle.  These now 
post-mitotic LRCs retain developmental plasticity for some time, enabling them to re-acquire stem 
cell activity given a favorable environment (Figures 1.2 and 1.3).  
The LRCs of the intestine and other non-dividing cells are often referred to as being 
quiescent (Buczacki et al., 2013), however the distinction between true quiescence and 
differentiation/G1 arrest are unclear. For example, LRCs are referred to as being quiescent, yet 
the vast majority of these cells are arrested in the G1 phase of cell cycle, typical of a terminally 
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differentiated cell (Li et al., 2016b).  The definition of quiescence, to be “in a state or period of 
inactivity or dormancy” implies that 1) quiescent cells have a dormant genome (and thus reside in 
G0 not G1, usually distinguished by global levels of transcription and cellular metabolism) and 
that 2) quiescent cells can re-enter the cycle and act as a stem/progenitor cell.  By this definition, 
the vast majority of non-dividing cells are not quiescent, and thus drawing this distinction 
becomes important for creating clear framework for understanding the intestinal stem cell 
compartment.   
Developmental plasticity downstream of the CBC state can also be observed in transit-
amplifying (TA) cells committing to the enterocyte lineage (Figure 1.2).  These cells, marked with 
Alpi-CreER, give rise to full crypt-villus lineage tracing events at low frequency in response to 
genetic ablation of CBCs using an Lgr5-DTR allele (Tetteh et al., 2016).  Similarly, generation of 
small intestinal organoids followed by Lgr5-DTR CBC ablation results in organoid maintenance 
from an Alpi-CreER-marked population.  While this provides some evidence for plasticity 
downstream of the CBC state, whether this mechanism functionally contributes to intestinal 
regeneration in any physiological injury setting is unclear.  It would be expected that an injury 
which kills cycling cells such as DNA damage would ablate both the CBC compartment as well as 
these Alpi-CreER-marked transit-amplifying cells (Tao et al., 2015). 
Ultimately, the ability of short-term LRCs and transit-amplifying cells displaying hallmarks of 
lineage commitment downstream of the CBC state to acquire stem cell properties, either forming 
organoids in vitro or giving rise to clonal lineage tracing events in vivo is a clear demonstration of 
the plasticity of cellular identity within the intestinal crypt. 
 
Signaling pathways regulating intestinal stem cells’ activity and differentiation 
The self-renewal and differentiation activities of intestinal stem cells are precisely 
regulated by signaling molecules such as cytokines and growth factors, which are secreted from 
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epithelial cells and from non-epithelial cells surrounding the intestinal epithelium. These include 
fibroblasts, immune cells, and enteric neurons. Genetic studies have shown that various signaling 
pathways, including Wnt, Notch, Bmp, and EGF signaling pathways regulate the balance 
between proliferation and differentiation in the intestinal epithelium (Moore and Lemischka, 2006). 
 
Wnt signaling 
In the gastrointestinal (GI) tract the Wnt pathway is required for crypt base proliferation, 
differentiation to the secretory lineage, and migration along the crypt-villus axis (Gregorieff et al., 
2005; Haramis et al., 2004; He et al., 2004). Many human diseases, including cancer and 
diabetes, are associated with mutation in the Wnt signaling pathway (Clevers and Nusse, 2012). 
The Wnt signaling pathway mostly acts over short distances through binding of Wnt ligands to a 
heterodimeric receptor consisting of Frizzled (Fz) and Lrp5/6 proteins. The output of Wnt ligand 
binding to its receptor is inhibition of β-catenin degradation through the multiprotein destruction 
complex consisting of Axin, Apc, WTX, CK1α/δ and Gsk3α/β (Aberle et al., 1997).  
In the absence of Wnt ligand, phosphorylation of β-catenin by CK1α/δ and Gsk3α/β leads 
to its degradation by E3 ubiquitin ligase complex. Binding of Wnt ligand to its receptor recruits the 
destruction complex to the plasma membrane through interaction between Lrp and Axin, which 
acts as the scaffold of the destruction complex. Localization of destruction complex to the cell 
membrane and inhibition of Gsk3α/β by Lrp prevents degradation of β-catenin leading to 
saturation of the destruction complex. Thus, newly translated β-catenin is not degraded by the 
destruction complex and can translocate to the nucleus, leading to transcriptional activation of β-
catenin target genes (Li et al., 2012; Stamos et al., 2014).  
In one of the first functional studies of the role of Wnt signaling in intestinal crypt biology, 
germline disruption of Tcf4, the transcriptional activation partner of β-catenin, led to loss of 
proliferative compartments in the intestinal epithelium of neonatal mice (Korinek et al., 1998). In 
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the adult intestine, ubiquitous deletion of Tcf4 using a Villin-CreERT2 expressing transgenic 
mouse model caused rapid loss of CBCs (van Es et al., 2012b) and intestinal overexpression of 
the secreted Wnt inhibitor Dickkopf 1 (Dkk1) led to loss of crypts and decreased epithelial 
proliferation (Kuhnert et al., 2004). 
Lgr5, one of the known targets of Wnt signaling pathway, marks the actively cycling 
CBCs (Barker et al., 2007). CBC-specific activation of the Wnt pathway by inactivating mutations 
in APC stabilizes β-catenin and confers stem cells with a competitive advantage over their wild-
type counterparts resulting in rapid formation of adenomas (Barker et al., 2009; Snippert et al., 
2014; Vermeulen et al., 2013). 
The stem cell niche provides signaling cues that maintain stem cell self-renewal and 
dictate the balance of stem cell proliferation with differentiation. The importance of Wnt signaling 
for maintenance of intestinal epithelium, and specifically CBC function, raised the question about 
the cellular identity of the Wnt-secreting niche. Sato et al. originally hypothesized that Paneth 
cells form the CBC niche because they are intercalated at the crypt base between CBCs, secrete 
Wnt3, Egf, and the Notch ligand Dll4, their co-culture with CBCs enhances organoid formation 
efficiency from CBCs in vitro, and addition of Wnt3a can substitute co-culturing Paneth cells with 
CBCs (Sato et al., 2011).   
Despite these findings, several recent studies have called into question the role of the 
Paneth cells in supporting CBCs. Paneth cell loss via deletion of Atoh1/Math1 (the master 
secretory lineage specifying transcription factor) has no effect on CBCs and intestinal 
homeostasis under basal conditions, nor does it adversely affect regeneration following radiation 
injury (Durand et al., 2012; Kim et al., 2012). Moreover, epithelial-specific deletion of Wnt3 or Wnt 
processing protein Porcupine (Porcn) using Villin-CreER has no effect on intestinal stem cell 
activity (Farin et al., 2012; Kabiri et al., 2014a), suggesting the presence of non-epithelial sources 
of Wnt and other niche factors.  
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Turning to potential non-epithelial Wnt sources, deletion of Porcn in myofibroblasts using 
Myh11-CreER alone or in combination with epithelial deletion using Villin-CreER did not affect 
intestinal stem cell proliferation or differentiation (San Roman et al., 2014). In contrast, a recent 
study showed that rare Foxl1+ cells, which are located just under the intestinal epithelium, have 
mesenchymal characteristics, highly express niche factors such as Wnt and Fgf2, and are distinct 
from myofibroblasts.  Further, their ablation using diphtheria toxin halts proliferation 
and Wnt signaling activity in the intestinal stem cell compartment, leading to tissue failure. This is 
in contrast to what is observed upon Paneth cell ablation. This recent study, for the first time, 
shows the requirement for a single cell type in providing niche signals to CBCs(Aoki et al., 2016). 
However, whether the requirement for Foxl1+ cells is due to their production of Wnt ligands or 
other niche factors remains to be definitively demonstrated 
 
Notch 
Notch signaling pathway is an evolutionarily conserved pathway known to be involved in cell fate 
determination during development, and is dysregulated in different human cancers (Katoh and 
Katoh, 2007). Notch signaling is active in the stem and progenitor zone of gastrointestinal tract 
such as in the intestinal and colonic crypts (van Es et al., 2005; Jensen et al., 2000; Riccio et al., 
2008; Schröder and Gossler, 2002). Activation of Notch signaling expands the proliferative zone 
in the intestinal epithelium, represses secretory cell differentiation, and increases the number of 
absorptive enterocytes (Fre et al., 2005; Stanger et al., 2005). Conversely, Notch inhibition leads 
to loss of proliferation, loss of CBCs, and enhanced differentiation to goblet cells and 
enteroendocrine cells in the intestine. Consistently, deletion of Atoh1, which is repressed 
downstream of active Notch, prevents differentiation toward the secretory cell types including 
goblet, Paneth, and enteroendocrine cells (van Es et al., 2005, 2010; Milano et al., 2004; Shroyer 
et al., 2007) while induction of Atoh1 promotes differentiation towards this lineage (Ueo et al., 
2012). The suppression of differentiation to the secretory lineage is oncogenic in gastric cancer; 
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inhibition of this suppression by Notch signaling inhibitors could be a therapeutic strategy (Fischer 
et al., 2011; Hoey et al., 2009; Liu et al., 2011). 
Notch signaling acts between two cells: one presents the Notch ligand, and the adjacent 
cell presents the Notch receptor. Activation of Notch signaling in the cell with the Notch receptor 
leads to release of the Notch intracellular domain (NICD) and its translocation to the nucleolus. In 
the nucleus, NICD along with Rbpj, one of the principle effectors of the Notch pathway, regulates 
transcription of Notch target genes (Logeat et al., 1998). Secretory progenitor cells, Paneth cells, 
and goblet cells express the Notch ligands Delta-like 1 and 4 (Dll1 and Dll4) and present these 
ligands to their adjacent cells in the intestinal epithelium (Fre et al., 2005; Sato et al., 2011; 
VanDussen et al., 2012; Vooijs et al., 2007). 
 
Bmp 
Juvenile polyposis syndrome (JPS), which is the development of multiple benign tumors 
in the gastrointestinal tract, is caused by loss-of-function mutations in the Bone morphogenetic 
protein (BMP) signaling pathway (Howe et al., 1998, 2001). BMP is also one of the major barriers 
to colorectal cancer development (Hardwick et al., 2008). Bmp signaling acts through binding of 
Bmp ligands (BMP2 and BMP4) to a type II receptor, recruiting a type I receptor (Bmpr1a or 
Bmpr1b) and finally activation of SMAD transcription factors. In the intestine, BMP ligands and 
their receptors are expressed both in mesenchymal and epithelial cells. Bmpr1a is expressed in 
the crypt base and in the intestinal villi, but not in the transit amplifying zone. Noggin, a BMP 
antagonist, is expressed in the mesenchyme adjacent to the crypt base and some cells located 
higher in the crypts (He et al., 2004). As a result of the interplay between BMP agonist, receptors, 
and antagonists, BMP signaling is only active in the villi and some cells around the +4 position of 
the intestine and in the in the intercrypt epithelial cells of the colon (Haramis et al., 2004; 
Hardwick et al., 2008; He et al., 2004). Inhibition of BMP signaling via overexpression of Noggin 
or deletion of BMP receptor leads to expansion of stem cell compartment and generation of the 
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ectopic crypts (Haramis et al., 2004; He et al., 2004). Consistently, absence of Noggin in organoid 
culture media causes stem cell differentiation (Sato et al., 2011). Interestingly, following 
Doxorubicin-induced tissue injury, when surviving stem cells become activated to repopulate the 
damaged intestinal epithelium, chordin-like 2, a BMP antagonist, is upregulated in the 
mesenchyme (Seiler et al., 2015) This result emphasizes the role of Bmp signaling in regulation 
of intestinal epithelial proliferation. 
 
Hippo 
The Hippo pathway is highly conserved from Drosophila melanogaster to mammals and it 
responds to a variety of signals, including stress (oxidative stress, hypoxia, unfolded proteins, and 
mechanical stress), hormones, and growth factors (Bossuyt et al., 2014; Ma et al., 2015; Meng et 
al., 2016; Shao et al., 2014; Wu et al., 2015). The primary components of the Hippo pathway are 
six kinases, including MST1 and MST2, and two homolog transcriptional co-activators, YAP and 
TAZ (Yu and Guan, 2013). The Hippo pathway is involved in regulating cell fate decision, cell 
survival, proliferation, and organ size. Dysregulation of the Hippo pathway can lead to malignant 
transformation and failure in tissue regeneration (Lee et al., 2010; Lei et al., 2008; Shen and 
Stanger, 2015; Yimlamai et al., 2014).  
Activation of the kinase cascade leads to phosphorylation of YAP/TAZ transcriptional co-
activators. This phosphorylation regulates the cellular localization and stability of these proteins. 
When the pathway is active, phosphorylated YAP/TAZ are sequestered to the cytoplasm and are 
destined for degradation. When the pathway is off, unphosphorylated YAP/TAZ moves to the 
nucleus and interacts with the TEAD family of DNA-binding proteins, which alone have low 
transcriptional activity. The interaction between YAP/TAZ and TEAD leads to formation of a 
transcriptionally active complex and transcription of genes important in cell survival and 
proliferation (Zhao et al., 2007, 2008, 2010). YAP and TAZ are dispensable for intestinal 
homeostasis under basal conditions (YAP/TAZ knockdown reduces the rate of proliferation of 
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CBCs and differentiation to goblet cells) but are necessary for intestinal regeneration following 
damage and for tumorigenesis in an Apc null mouse model of colorectal cancer (Azzolin et al., 
2014; Barry et al., 2013; Cai et al., 2010; Zhou et al., 2011). 
 
EGF 
Epidermal growth factor (EGF) is one of the main components of organoid formation 
media from intestinal stem cells (Sato et al., 2009). EGF receptor (EGFR/ErbB/HER1) belongs to 
the ErbB receptor tyrosine kinase family that signals through Akt, MAPK, and many other 
pathways to regulate cell proliferation, migration, differentiation, apoptosis, and cell motility 
(Roskoski, 2014). Phosphorylated EGFR (activated receptor) is detected in all intestinal crypt 
cells but it is at its highest level at around +3 to +12 cell positions from the crypt base. Lrig1, a 
negative regulators of EGF signaling, is also expressed in the intestinal crypts and its loss causes 
crypt hyperplasia (Wong et al., 2012).  
Activation of EGF signaling could lead to upregulation of the mechanistic target of 
Rapamycin (mTOR) signaling pathway. mTOR signaling integrates the intracellular and 
extracellular signals such as energy, stress, nutrients, growth factors, hormones and, it serves as 
one of the main regulator of cell metabolism, growth, and proliferation. mTOR signaling is highly 
upregulated in human cancers including colorectal cancer, however, the components of this 
signaling pathway are infrequently found to be mutated.  This means that hyperactivation of 
mTOR signaling is mainly due to mutations in its upstream regulators such as components of 
EGF or Wnt signaling. For example, around 50% of colorectal cancers have been found to have 
increased copy numbers of EGFR gene (Cappuzzo et al., 2008). Mutations in 
phosphatidylinositol-3-kinase (PI3K), which is downstream of EGF receptor activation and 
upstream of mTOR, can also be identified in 32% of colorectal cancer patients (Samuels et al., 
2004). Similarly, mutation in APC, one of the main component of Wnt signaling pathway, is found 
in 80% of sporadic colorectal tumors (Kwong and Dove, 2009). 
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mTOR, which is a serine threonine kinase, can be part of two different multiprotein 
complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The mTORC1 
signaling pathway is the master regulator of anabolic processes such as protein and lipid 
synthesis (Laplante and Sabatini, 2009) and, besides receiving input from signaling pathways 
such as EGF and Wnt signaling, availability of nutrients such as amino acids can directly regulate 
mTORC1 activity (Inoki et al., 2006; Valvezan et al., 2012, 2014; Zoncu et al., 2011). mTORC1 
signaling is required for intestinal tumorigenesis and regeneration following injury (Ashton et al., 
2010; Faller et al., 2015; Fujishita et al., 2008; Gulhati et al., 2009). Surprisingly, despite its clear 
role in cell growth and proliferation, mTORC1 signaling is dispensable for basal homeostasis of 
adult intestine (Faller et al., 2015), the most highly proliferative tissue in mammalian body. 
mTORC2 is believed to be involved in cell survival, proliferation, and cytoskeletal organization 
but, in contrast to mTORC1, very little is known about mTORC2 (Laplante and Sabatini, 2009).  
 
Dysregulation of signaling in the intestinal stem cells  
Homeostasis in adult tissues, particularly in the highly proliferative ones, is dependent on 
the appropriate function of resident stem cells: on their capacity to self-renew and differentiate 
and replace damaged or dying cells. Thus, perturbations in the function of stem cells could be 
excessively costly compared to perturbations in the function of terminally differentiated cells. 
Dysregulation in adult stem cells not only has consequences for the originally affected cells, but 
also for their progeny. Altered self-renewal of adult stem cells can result in oncogenic 
transformation if it is enhanced, or decline in tissue regeneration if it is impaired (Noah and 
Shroyer, 2013). 
Dysregulation of stem cell self-renewal underlies most hematopoietic malignancies and 
has been implicated in cancers of the breast, gastrointestinal system, central nervous system, 
and many other solid tumors (Rossi et al., 2008). Colorectal cancer, one of the common cancer 
types of the gastrointestinal tract, is a leading cause of death in the world. Colorectal cancer 
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evolves clonally by acquiring a series of mutations that ultimately convert normal epithelial cells to 
metastatic carcinoma. The initiating mutation, which provides a selective growth advantage to a 
normal epithelial cell, is thought to be homozygous inactivation of the APC tumor suppressor 
gene. APC is a large protein with diverse cellular functions, including antagonism of canonical 
Wnt signaling, microtubule nucleation, and RNA binding (van Es et al., 2005, 2010; Milano et al., 
2004; Shroyer et al., 2007).  Acute and broad loss of Apc throughout the epithelium in mice 
results in crypt hyperplasia, differentiation block, and crypt fission (Sansom et al., 2004). 
Subsequent mutations in KRAS, TGF-B, P53, and PI3K pathways occur later and result in clone 
expansion and progression from small adenoma to malignant invasive carcinoma (Markowitz et 
al., 1995; Samuels and Waldman, 2010; Sansom et al., 2004; Vogelstein et al., 1988, 2013). 
Inherited mutation, aging, and environmental factors such as diet may also result in 
reduced effectiveness of stem cells in tissue regeneration. The monolayer of the intestinal 
epithelial cells provides a selective barrier to microbiota, nutrient, water, and xenobiotics in the 
lumen. The rapid rate of epithelial cell proliferation in the small intestine makes gastrointestinal 
toxicity one of the most common off-target effects of a variety of radiation/chemo-therapy for 
cancer patients. Mucositis, ulceration, necrosis, and perforation are some of the off-target effects 
of radiation/chemo-therapy approaches partly as a result of crypt apoptosis and villous atrophy 
after receiving these treatments. Damage in the intestinal epithelium can lead to inflammation, 
electrolyte imbalance, dehydration, malnutrition, and many other unwanted complications for 
cancer patients (Carneiro-Filho et al., 2004; Keefe et al., 2000; Melichar and Zezulová, 2011; 
Nejdfors et al., 2000; Russo et al., 2013). 
Disruption in the barrier function of the intestinal epithelium may also happen in 
inflammatory bowel diseases (IBD) or as a result of ischemia-reperfusion. Intestinal ischemia-
reperfusion may occur during variety of surgeries including abdominal surgery, small bowel 
transplantation, and cardiopulmonary bypass. Disruption of barrier function can lead to high 
mortality rate due to translocation of bacteria into the body circulation and induction of systemic 
inflammation (Blikslager et al., 2007; Grootjans et al., 2010). Regeneration of the intestinal 
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epithelial layer is associated with a more favorable prognosis for IBD patients, including lower 
relapse and hospitalization rates (Shah et al., 2016). Thus, understanding the underlying 
molecular mechanisms of damage to the intestinal epithelium and regeneration following injuries 
caused by radiotherapy, chemotherapy, IBD, and ischemia-reperfusion may improve our ability to 
prevent damage and improve repair, and thus maintain the integrity of the epithelial barrier. 
In this work, I describe the cellular and molecular underpinnings of intestinal regeneration 
in response to high dose radiation. I introduce methods to protect the tissue against injury, and to 
enhance the regenerative response to repair the damage. 
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Figure 1. 1. Intestinal stem cell fate determination under basal conditions. 
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Figure 1.1. Intestinal stem cell fate determination under basal conditions  
In the resting state, reserve ISCs (blue) periodically divide to give rise to the active crypt base 
columnar stem cells (CBCs, green). These active CBCs then either produce transit-amplify 
progeny (T/A cells, dark grey), which go on to divide very rapidly in order to produce large 
quantities of enterocytes (light grey), or can generate secretory progenitor cells (maroon).  These 
secretory progenitor cells then commit to either Paneth, goblet, or enteroendocrine cell lineages 
(yellow, navy blue, or purple, respectively). 
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Figure 1. 2. Intestinal regeneration after injury 
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Figure 1.2. Intestinal regeneration after injury 
Exposure to DNA damaging agents such as high-dose gamma radiation or chemotherapeutics 
ablates actively cycling cells, including CBCs and transit-amplifying cells. Some cells are able to 
survive DNA damage, and some of these cells can contribute to the post-injury regenerative 
process.  In response to DNA damage, reserve ISCs enter the cell cycle to replenish the CBC 
compartment and epithelium.  Additionally, some reports indicate that WntLow CBCs above the 
crypt base as well as cells downstream of the CBC can resist DNA damage-induced cell death 
and contribute to repopulation, including a rare subpopulation of secretory progenitor cells. The 
quantitative contribution of these cells to regeneration based on lineage tracing is, however, 
minimal, and no evidence exists demonstrating its functional importance.  Further, in non-
physiological injury settings in which CBCs are genetically ablated with diphtheria toxin, transit-
amplifying cells marked by Alpi-CreER can fall back into the CBC niche and re-establish stem cell 
identity. 
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Figure 1. 3. Model of intestinal stem cell compartment organization 
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Figure 1.3. Model of intestinal stem cell compartment organization 
  Atop the hierarchy resides a population of rare stem cells that lack activity of the canonical Wnt 
pathway and reside in the quiescent G0 state.  During homeostasis, these cells periodically divide 
to generate CBCs driven by high Wnt pathway activity and marked by Lgr5 expression. Whether 
CBCs can re-enter the Wntoff reserve ISC state remains an outstanding question.  CBCs divide 
symmetrically and stochastically and give rise to transit-amplifying cells, which begin to lose 
developmental potency as they undergo the massive proliferation required to generate large 
numbers of short-lived enterocytes.  Conversely, CBCs can activate Dll1 expression and commit 
to the secretory lineage.  These secretory progenitor cells retain some developmental potency, 
even after they exit the cell cycle and retain DNA label while they acquire hallmarks of 
enteroendocrine and Paneth cell lineages.  The secretory progenitor cells can also give rise to 
goblet cells, a fate decision that is presumably coupled to additional cell divisions as no evidence 
for goblet cell identity is found in the short-term label retaining cell population.  Long-term label 
retaining cells are terminally differentiated Paneth cells that have lost developmental potency. 
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CHAPTER 2 
 
 
Materials and Methods 
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Mouse Strains  
We obtained Bmi1-CreER (JAX strain 010531), Lgr5-EGFP-IRES-CreER (JAX strain 
008875), Tsc1 floxed (Jax mice strain 005680), Raptor floxed (Jax mice strain 013188), and R26-
CAG-LSL-tdTomato (JAX mice strain 007914) from the Jackson Laboratory. Hopx-CreER (JAX 
strain 017606) mice were generated at the Perelman School of Medicine in the laboratory of Dr. 
Jonathan Epstein, University of Pennsylvania. Generation of the TRE-Msi1 doxycycline-inducible 
mouse model and Msi1 and Msi2 conditional alleles was previously described (Li et al., 2015; 
Park et al., 2014). All mice were maintained on a C57/BL6N background. 
All experimental analyses were performed on three or more individual mice (male or 
female mice at 8–12 weeks of age). Controls and experimental groups were sex-matched 
littermates or age-matched, sex-matched non-littermates. To ablate Tsc1, Raptor, and Msi floxed 
alleles or to activate the R26-LSL-tdTomato or R26-LSL-DTA cassettes, Tamoxifen (Sigma) was 
dissolved in corn oil at 10mg/ml and 1mg was injected intraperitoneally per 20 gram of mouse 
body weight for each dose. To induce Msi1 gene expression, TRE-Msi1 and control (M2rtTA 
alone) mice received 1 mg/ml doxycycline hyclate (Sigma-Aldrich) in drinking water, 
supplemented with 1% (w/v) sucrose.  
To activate mTORC1 signaling in vivo using nutrient modulation 1.5% (w/v) Leucine was 
dissolved in the drinking water and was given to mice during the time mentioned specifically for 
each experiment. To inhibit mTORC1 signaling non-genetically, Rapamycin (Selleck Chemical) 
was first reconstituted in absolute ethanol at 10 mg/ml and diluted in 5% Tween 80 (Sigma) and 
5% PEG-400 (Hampton Research) before injection. 5 mg Rapamycin per 1000 grams of mouse 
body weight was administered by daily intraperitoneal injection for the time indicated for each 
experiments. For assessing regenerative efficiency, mice were exposed to 12 Gy whole body γ-
irradiation and euthanized 3 days following radiation.  
To calorie restrict mice, the food consumption was first measured for a period of 1-2 
weeks and 60% of the food intake was given to calorie restricted mice daily for 4-6 weeks. All 
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mice in ad libitum group were fed irradiated rodent chow diet (Prolab RMH 3000, 5P00) and 
calorie restricted mice received irradiated chow diet fortified with vitamins and minerals (LabDiet, 
5B6V) to prevent nutrient deficiency in calorie restricted mice (Kalaany and Sabatini, 2009). 
During the period of calorie restriction, the food intake of the calorie-restricted mice was 
readjusted based on their control counterparts’ food consumption. Fasting experiments were 
done by removing the food for 16 hours from the mouse cages. 
All mouse protocols were approved by the Institutional Animal Care and Use Committee 
at the University of Pennsylvania under protocol 803415 to Dr. Christopher Lengner. 
 
Histology and Immunofluorescence 
Tissues were fixed in buffered formalin phosphate or Zinc formalin (Fisher Scientific) 
overnight at 4°C and then, were washed in PBS for 30 minutes and moved to 70% ethanol until 
the time of paraffin embedding. Staining was done on 5 um tissue sections from the jejunum. 
Tissue regeneration assays were don on sections stained with Hematoxylin and Eosin in the 
Morphology Core of the Penn Center for Molecular Studies in Digestive and Liver Diseases 
according to standard procedures. For immunostaining, antigen-retrieval was performed by 
heating slides in 10 mM Tris base, 1mM EDTA solution, 0.05% Tween 20, pH 9 with a pressure 
cooker.  
The following primary antibodies were used for immunostaining: Living Colors DsRed 
Monoclonal Antibody (1:200, Clontech, 632392), Phospho-S6 Ribosomal Protein Antibody (1:200, 
Cell Signaling, 4858), Anti-Ki67 Antibody (1:1000, leica novocastra, NCL-Ki67p), anti-Musashi1 
antibody (1:200, D270-3; MBL International), anti-Musashi2 antibody (1:200, NBP1-42029; Novus 
Biologicals), anti–β-catenin antibody (1:1,000, C7207; Sigma-Aldrich), anti– E-cadherin (1:200, 
13-1900; Invitrogen), Anti-PIP3 Antibody (1:50, echelon, Z-P345), and anti–lysozyme C antibody 
(C-19, 1:200, sc-27958; Santa Cruz Biotechnology, Inc.). Cy2-, Cy3- and Cy5- conjugated 
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secondary antibodies were obtained from the Jackson Immunoresearch Laboratories. 
Biotinylated secondary antibodies and DAB substrate kit for immunohistochemistry were 
purchased from Vector Laboratories. 
All quantifications were done on 20 to 40 randomly selected areas in jejunum on 
indicated number of mice for each experiment. Regenerative foci were defined as 10 or more 
adjacent chromophilic cells and a lumen in hematoxylin and eosin stained sections of intestinal 
jejunum of mice that were exposed to 12 Gy whole body γ-irradiation 3 days before the harvest 
time.  
For quantification of pS6, PIP3, and Msi1 fluorescence intensity in reserve ISCs of mice 
under ad libitum and calorie restricted diets, tdTomato+ populations were sorted by FACS, 
smeared over coverslips coated with CELL-TAK (354240; Corning), and allowed to settle at 370C 
for 10 min. The cells were subsequently fixed in 4% PFA and permeabilized in 0.5% Triton X-100 
before staining. Quantification of fluorescence intensity was done using MetaMorph Microscopy 
Automation and Image Analysis Software. 
 
Intestinal epithelial cell isolation and sorting 
Small intestine was dissected out of mouse of the appropriate genotype, opened 
longitudinally, and washed twice with cold HBSS. The tissue was incubated in 5mM EDTA/HBSS 
for 10 min at 40C on a rotating platform and then the villi were scraped off gently using glass 
cover slip. The intestine was cut into 0.5 cm fragments and placed into 5mM EDTA/HBSS for 30 
minutes on ice. Then the tissue fragments were transferred to fresh EDTA/HBSS buffer and 
vigorously pipetted until the tissue fragments floated. The supernatant was centrifuged at 1500 
rpm for 5 minutes to collect crypts. The isolated crypts were incubated in 0.8 mg/ml dispase 
(gibco) for ten minutes at room temperature and filtered through 100 um and 40 um filters to 
acquire single cell population of intestinal epithelial cells. For isolating live reserve ISCs for further 
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analysis using RNA-sequencing, immunoblotting, or immunofluorescence staining, we utilized 
Fluorescence activated cell sorting(FACS) sorting on BD FACS Aria II or BD FACS Jazz. 
 
Flow cytometry 
Single cell suspension was obtained as described above. Frequency of Lgr5+ stem cells 
was quantified by flow cytometry on cells isolated from Lgr5-eGFP-IRES-CreER mice. Frequency 
of reserve ISCs was quantified by flow cytometry on cells isolated from Bim1-CreER/Hopx-
CreER::Lox-Stop-Lox-tdTomato mice, 18 hours after tamoxifen injection. 1 µg/ml DAPI was used 
to exclude dead cells from the quantification of ISCs. EdU incorporation was assessed by 
intraperitoneal injection of mice with 30 mg/kg EdU 4 hours before tissue harvest, and 
incorporation was analyzed with Click-it EdU assay kit (Life technologies, C10634) and flow-
cytometry. To assess apoptotic cell death, single cell suspension was stained for cleaved 
Caspase3 using BD Cytofix/Cytoperm kit and cleaved Caspase 3 monoclonal antibody (1:50, Cell 
Signaling Technology 8788S). 
For quiescence (G0) analysis, tdTomato+ cells were sorted by FACS from experimental 
and control mice into 100% ethanol and placed at 4°C overnight. The cells were then stained with 
pyronin Y (1 µg/ml) and DAPI (10 µg/ ml) for 30 min before flow cytometric analysis.  
 
Quantitative RT-PCR  
1 µg total RNA was used in a 20-µl first-strand cDNA synthesis reaction (Thermo Fisher 
Scientific). SYBR green quantitative RT-PCR was performed under standard conditions using a 
QuantStudio 6 Flex (Thermo Fisher Scientific), and data were analyzed using QuantStudio RT-
PCR software. Custom primers were validated with standard SYBR green qRT-PCR. Data were 
normalized to housekeeping gene Gapdh. The following sets of primers were used to assess 
Msi1 and Msi mRNA expression levels: Msi1, 5′-GCCATG CTGATGTTCGACAA-3′ and 5′-
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CTACGATGTCCTCGCTCT CAA-3′; Msi2, 5′-GCGATGCTGATGTTCGACAA-3′ and 5′-TCT 
CCACAACGTCTTCATTCTCA-3′.  
 
Determination of recombination of Msi1 and Msi2 genes 
DNA was extracted from eGFP+ dtTomato+ sorted cells from Msi1flox/flox- ::Msi2flox/flox::Lgr5-
EGFP-IRES-CreER::LSl-tdTomato mice. DNA was resuspended in Tris/EDTA, and the 
concentration was normalized before PCR. The following sets of forward and reverse primers 
were used: Msi1 floxed and wild-type, 5′-CGGACTGGGAGAGGTTTCTT-3′ and 5′-
AGCTCCCCTGATTCCTGGT-3′; Msi2 floxed and wild-type, 5′- GCTCGGCTGACAAAGAAAGT-3′ 
and 5′-TCTCCTTGTTGCGCT CAGTA-3′; Msi2 null, 5′-CCTGTCTGGTTGCTTCCTCG-3′ and 5′- 
GAGCCAACTCGCTAGCTTG-3′. These primers were used to detect wild-type, floxed, and null 
alleles using Hot Start DNA polymerase (CB4040; Denville Scientific). 
 
RNA-Sequencing 
Reserve ISCs were FACS sorted form Hopx-CreER::LSL-tdTomato mice under ad libitum 
or calorie restricted diet, 18 hours after one single dose of Tamoxifen, into TRIzol LS 
(ThermoFisher). After phase separation using the standard TRIzol LS protocol, the aqueous 
phase containing RNA was mixed with 70% ethanol and transferred to RNeasy MinElute spin 
columns (QIAGEN). The cleanup and further concentration of the RNA was done using the 
standard procedure of RNeasy MinElute Cleanup Kit. The cDNA synthesis was done using 
SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing (Clontech) and the library was prepared 
using Nextera XT DNA Library Prep kit (Illumina) and sequenced using Illumina NextSeq 500. 
Sequencing of mRNA libraries generated 20-40 million high-quality 75-bp 
reads/sample. Raw sample data were mapped to the mouse reference transcriptome using 
kallisto and data were analyzed in the statistical computing environment R. RUVseq and edgeR 
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bioconductor R packages were used for differential gene expression analysis. The effect of 
calorie restriction was estimated using a paired analysis (ad libitum-calorie restriction) in order to 
account for isolation, time, and litter dependent differences. 
Microarray analysis 
Total RNA was isolated from crypts of mouse small intestinal epithelium cells from three 
control and three MsiDKO mice that received five doses of Tamoxifen for five consecutive days 1 
week before tissue harvest. Total RNA was isolated using TRIzol Reagent (Thermo Fisher 
Scientific) according to the manufacturer’s instructions. Total RNA was DNase treated with an 
RNase-free DNase kit (Zymo Research). Purified RNA was submitted to the University of 
Pennsylvania Molecular Profiling Core, where samples were labeled and hybridized to Affymetrix 
Mouse Gene 1.0ST arrays. Microarray data were analyzed using Partek Genomics Suite 
software. After RMA background subtraction and normalization, one-way analysis of variance 
between controls and MsiDKO was run to compute p-values of significance and F statistic for 
each probe set. The q value, a measure of false discovery rate (FDR), was computed within the 
significance analysis of microarrays software for each probe set by running an unpaired t test. 
The FDR values were integrated with the one-way analysis of variance results. The set of 
differentially expressed genes were selected as those that were significant at an FDR cutoff of 
5% and a p-value of 0.1 and that changed at least 1.5-fold in either direction in the MsiDKO group 
compared with the control group. 
 
Immunoblotting 
Isolated crypt cells or FACS sorted reserve ISCs were lysed in ice-cold RIPA buffer 
(50mM Tris pH8.0, 150mM NaCl, 1% NP40, 0.5% deoxycholate, 0.1% SDS) and one tablet of 
protease inhibitors (Roche, 11697498001) per 50 ml. The soluble fractions of cell lysates were 
isolated by centrifugation at 12,000 r.p.m. for 15 min. Proteins extracts were denatured by the 
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addition of sample buffer, boiled for 5min, resolved by 12% SDS–PAGE, and transferred to PVDF 
membranes (GE Healthcare). Membranes were blocked in 5% BSA (Sigma) and then incubated 
with anti- Phospho-S6 Ribosomal Protein primary antibody (1:1000, Cell Signaling, 4858), and 
beta Actin antibody [AC-15](1:5000, Abcam, Ab6276), followed by incubation with a horseradish 
peroxidase (HRP) conjugated secondary anti-rabbit (1:2,000, Cell Signaling, 7074) or anti-mouse 
antibody (1:1000, cell signaling, 7076). Immunoreactive proteins were visualized using LumiGLO 
chemiluminescent substrate (Pierce). 
 
Organoid culture 
For crypt culture, 50 isolated crypts were mixed with 50 µl Matrigel (BD) and plated in 24-
well plates. For single cell organoid formation assays, a total of 1,000 tdTomato+ cells from Hopx-
CreER::tdTomato mice were sorted into each well of 96-well-plate coated with Matrigel (BD 
Bioscience) and containing crypt culture medium (Advanced DMEM/F12 containing growth 
factors (50 ng/ml EGF (Invitrogen), 0.5 µg/ml R-spondin 1 (Wistar Institute protein production 
facility), 100 ng/ml Noggin (Peprotech) and 3 µM GSK-3 inhibitor (CHIR99021, Stemgent)). Final 
concentration of 10uM Leucine and Rapamycin was added to culture media for 3 days.  
 
Fluidigm single-cell gene expression 
The two-step single-cell gene-expression protocol (advanced development protocol) from 
Fluidigm was adopted for this study. Briefly, 5 μl of RT Mix Solution which includes 1.2 μl 5× VILO 
Reaction Mix (Life Technologies; 11754-250), 0.3 μl SUPERase-In (Life Technologies; AM2696), 
and 0.25 μl 10% NP40 (Thermo Scientific; 28324) was dispensed into each well of 96-well plate. 
Single cells were sorted into the well directly. The plate was vortexed and immediately frozen on 
dry ice. For room temperature cycling, the plate was thawed on ice and RNA denatured by 
incubating at 65°C for 90 s and then chilled on ice for 5 min. Each well was supplemented with 
1 μl mixture of 10x SuperScript Enzyme Mix (Life Technologies; 11754-250) and T4 Gene 32 
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Protein (New England BioLabs; PN M0300S). mRNA was reverse transcribed into cDNA 
following the thermal cycling conditions below: 25°C, 5 min/50°C, 30 min/55°C, 25 min/60°C, 
5 min/70°C, and 10 min. Resulting cDNA was preamplified with 50 nM primer mix for 23 PCR 
cycles (96°C for 5 s and 60°C for 4 min) and then treated with ExoI for 30 min to remove 
unincorporated primers. The final product was diluted 1:3 with Tris-EDTA (TE) buffer. For each 
chip sample inlet, 2.25 μl diluted cDNA, 2.5 μl 2× Sso Fast EvaGreen supermix with low ROX, 
and 0.25 μl of Fluidigm sample loading agent were added. Individual gene-specific DELTAgene 
assays were diluted at 1:10 ratios with TE buffer. Two and a half microliters of each primer was 
then mixed with 2.5 μl assay loading agent inserted into chip “assay” inlets. Chip loading and 
PCR was performed according to the manufacturer’s protocol. The data were analyzed by 
Fluidigm Gene Expression Analysis Package. 
Genes analyzed include: Areg, Ascl2, Atoh1, Axin2, Bmi1, Bmpr1a, Ccnd1, Cdkn1a, 
Cdx1, Chga, Cubn, Dll4, Dvl2, Efnb1, Epas1, Ephb2, Ereg, Fut2, Gapdh, Gsk3b, Gusb, H6pd, 
Hes1, Hes5, Hif1a, Hopx, Jag1, Lgr5, Lrig1, Lyz2, Msi1, Msi2, Myb, Myc, Notch1, Numb, Olfm4, 
Pcna, Ppargc1b, Rhoa, Saa2, Sirt3, Sox9, Tat, Tcf4, Tert, Wnt3, and Wnt6.  
 
Statistical analysis 
We performed Shapiro-Wilk test to assess normality and calculated statistical 
significance using Mann–Whitney for non-normal and student t-test for normal data sets. Error 
bars reflect standard deviation. For animal studies, samples were only excluded from 
experiments if animals were considered unhealthy. 
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CHAPTER 3 
 
 
Calorie restriction governs intestinal epithelial regeneration through cell autonomous 
regulation of mTORC1 in reserve stem cells 
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Introduction 
Calorie restriction (CR-receiving fewer calories while maintaining adequate essential 
nutrients) is one of the most well-established interventions that prolongs life span and retards 
aging across numerous species, possibly by preserving stem and progenitor cell function, which 
normally declines with age (Colman et al., 2009; Guarente, 2005; Houthoofd and Vanfleteren, 
2006; McCay et al., 1989). Short-term calorie restriction in healthy young animals enhances the 
recovery from injury in several tissues including skeletal muscle and small intestine (Cerletti et al., 
2012; Yilmaz et al., 2012). 
In the intestinal epithelium, the most highly proliferative tissue in the body, the existence 
of both quiescent (residing in outside the cell cycle in G0) and actively cycling intestinal stem cells 
(ISCs) in the crypts is becoming increasingly clear. Actively proliferating stem cells are located at 
the base of the crypts (crypt-base columnar stem cells, CBCs), contribute robustly to tissue 
homeostasis under basal conditions, and exhibit high expression of canonical Wnt pathway target 
genes including Lgr5 (Lgr5high) (Barker et al., 2007). Extensive research on the effect of calorie 
restriction on Lgr5high CBCs has demonstrated that CR increases the number of actively cycling 
Lgr5high CBCs in response to signals sent from adjacent Paneth cells that sense nutrient 
availability (Igarashi and Guarente, 2016; Yilmaz et al., 2012). However, high Wnt activity in 
cycling Lgr5high CBCs sensitizes them to DNA damaging injury where they are quantitatively 
ablated, and the functional contribution of CBCs to the enhanced regenerative response to injury 
after calorie restriction has never been tested (Tao et al., 2015; Tian et al., 2011). In addition, 
genetic ablation of Paneth cells has no effect on the regenerative capacity of the epithelium after 
high-dose radiation injury (Durand et al., 2012).  Thus, the specific cell type, and by extension the 
underlying molecular mechanism, responsible for the enhanced regenerative capacity of the 
calorie restricted epithelium, remains unknown. 
In addition to the Lgr5high CBCs, another population of more radioresistant, slower cycling 
ISCs has been described in the intestinal crypts, generally referred to as reserve ISCs. Reserve 
ISCs are located higher in the crypts outside of the WntHigh zone and are highly enriched in 
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populations marked by Bmi1-CreER and Hopx-CreER knockin alleles and an mTERT-CreER 
transgene (Montgomery et al., 2011; Takeda et al., 2011; Tian et al., 2011). These cells are also 
likely represented in populations of cells marked by more broadly expressed reporter alleles 
(Asfaha et al., 2015; Li et al., 2016a; Powell et al., 2012). Reserve ISCs are more resistant to 
DNA damage than active CBCs, possibly due to their slower cycling rate, residence in G0, and 
lack of canonical Wnt pathway activity (Li et al., 2014, 2016c; Yousefi et al., 2016). It is well-
established that these cells undergo a robust proliferative response and contribute broadly to 
regeneration of the intestinal epithelium following DNA damage, particularly high dose (>12Gy) 
ionizing radiation (Montgomery et al., 2011; Tao et al., 2015; Yan et al., 2012; Yousefi et al., 
2016). It is also worth noting here that these reserve ISCs appear to be a distinct population from 
non-cycling (G1 arrested), label-retaining secretory progenitor cells (Buczacki et al., 2013; Li et 
al., 2016c) 
We investigated the response of reserve ISCs to CR and subsequent DNA damaging 
injury.  We find that the reserve intestinal stem cell compartment expands in response to calorie 
restriction, contributes robustly to the CR-enhanced regenerative capacity of the epithelium, and 
is functionally important for optimal regeneration following radiation injury. We demonstrate that 
tight, cell-autonomous regulation of mechanistic target of Rapamycin complex 1 (mTORC1) 
signaling in the reserve ISCs of CR mice governs the regenerative response of the epithelium in 
the face of DNA damage.  Our findings provide novel insight into the cell-type specificity of the 
beneficial effects of calorie restriction and have immediate implications for application of dietary 
modulation in patients exposed to DNA damaging agents. 
 
Results 
Calorie restriction increases reserve ISC availability and tissue regeneration efficiency 
To assess the effects of CR on reserve intestinal stem cells, we reduced the caloric 
intake of mice harboring Hopx-CreER::Rosa26LSL-tdTomato reporter alleles (HT mice) by 40% for a 
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period of four to six weeks starting at two months of age. Consistent with previous reports (Li et 
al., 2014; Takeda et al., 2011), we observed that 18 hours following induction of Hopx-CreER by 
Tamoxifen (Tam) injection in HT mice, single reserve ISCs were marked at around +4 position 
from the crypt base of ad libitum (AL) fed mice. Interestingly, CR dramatically (514%) increased 
the number of cells marked by Hopx-CreER activity in HT mice (Figure 3.1A and 3.1B). To 
investigate whether the increased number of tdTomato+ cells was a result of expanded pool of 
reserve ISCs or promiscuous activation of the Hopx locus, we examined the effect of CR on 
frequency of reserve ISCs marked with an independent allele, Bmi1-CreER::Rosa26LSL-tdTomato 
(BT) mice 18 hours after Tam induction. Bmi1-CreER and Hopx-CreER mark a largely 
overlapping (60%) population of reserve ISCs, however Hopx-CreER marks a more homogenous 
population relative to Bmi1-CreER (Li et al., 2014; Takeda et al., 2011; Tian et al., 2011; Yan et 
al., 2012). Consistent with this notion, we observed a robust but smaller increase (165%) in the 
number of cells marked in BT mice indicating that CR expanded the pool of reserve ISCs (Figure 
3.1B). Next, we measured proliferation of reserve ISCs following calorie restriction using EdU 
incorporation assays.  Surprisingly, we observed a reduction in proliferation of Hopx-CreER+ and 
Bmi1-CreER+ reserve ISCs, as well as the expected decreased proliferation in bulk intestinal 
epithelial cells (Figure 3.1C).  This indicates that the relative increase in reserve ISCs may be in 
part due to the decreased overall cellular mass of the calorie restricted tissue (Yilmaz et al., 
2012), along with a potential increase in self-renewal versus commitment of these cells under CR 
conditions. 
To assess stem cell activity within the expanded pool of reserve ISCs, we performed 
lineage tracing experiments in HT mice. Under basal conditions in ad libitum fed mice about 25% 
of reserve ISCs are in cycle at any given time and give rise to all the cell types in the intestinal 
epithelium, including CBCs, while the remainder reside in G0 (Figure 3.1D and Li et al., 2014; 
Sangiorgi and Capecchi, 2008; Takeda et al., 2011; Tian et al., 2011). Considering the 6.14-fold 
(514% increase) in frequency of Hopx-CreER+ ISCs and the 75% decrease in their proliferation 
following a period of CR, we would predict a roughly 1.5 folds increase in lineage tracing events 
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from these cells. Experimentally, we observed a 1.6-fold increase in tracing events emanating 
from reserve ISCs (defined as contiguous tdTomotao+ ribbons emanating from crypts and 
passing through the crypt-villus junction into villi) in CR mice relative to AL fed counterparts 
(Figure 3.1D), confirming the stem cell capacity of the expanded pool of Hopx-CreER+ cells.  
Next, we aimed to assess the functional contribution of CR-induced expansion of reserve 
ISC pool to the reported enhanced regeneration of the intestinal epithelium upon caloric 
restriction. We bred the Rosa26LSL-DTA allele (Voehringer et al., 2008) into the Hopx-CreER mice 
(HD mice).  In HD mice, a floxed stop cassette prevents expression of the diphtheria toxin 
fragment A (DTA) such that Tamoxifen injection results in selective ablation of Hopx-CreER+ 
cells. After 6 weeks of calorie restriction, we injected 3 doses of Tamoxifen to HD mice and their 
control counterparts (lacking Hopx-CreER), then exposed them to 12 Gy γ-irradiation (γ-IR) 3 
days after the last dose of Tamoxifen. We assessed regeneration efficiency by scoring the 
number of clonal regenerative foci per unit length of the intestine on histological sections. As 
previously reported (Yilmaz et al., 2012), we observed that calorie restriction enhanced 
regenerative capacity of the intestinal epithelium following injury relative to AL fed mice. 
Approximately 40% of this enhanced regenerative capacity was dependent on the presence 
Hopx-CreER+ reserve ISCs, emphasizing the functional importance of these cells in mediating 
beneficial effects of CR (Figure 3.1E).  The lack of complete abrogation of CR-enhanced 
regeneration may be due to effects on CBCs (Igarashi and Guarente, 2016; Yilmaz et al., 2012) 
as well as incomplete ablation of reserve ISCs due to inefficiencies of the tamoxifen-diphtheria 
toxin system, or a combination of these. 
Calorie restriction downregulates mTORC1 signaling in reserve ISCs 
To better understand the mechanisms underlying enhanced tissue regeneration from 
reserve ISCs following calorie restriction, we performed RNA sequencing on FACS-purified 
populations of reserve ISCs from control (AL) and CR mice. Gene set enrichment analysis 
(GSEA) of these transcriptome profiles revealed that genes encoding ribosomal proteins and 
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involved in translation were contained in the most highly depleted gene sets in reserve ISCs of 
calorie restricted mice relative to ad libitum fed control counterparts (Figure 3.2A). Ribosome 
biogenesis is a primary determinant of cellular translational capacity and accordingly has an 
essential role in the control of cell growth. The mechanistic target of rapamycin complex 1 
(mTORC1) is one of the major pathways coupling nutrient availability to the regulation of 
ribosome biogenesis and has been reported to regulate effects of calorie restriction in a number 
of somatic tissues (Dibble and Manning, 2013; Igarashi and Guarente, 2016; Powers and Walter, 
1999; Yilmaz et al., 2012). Thus, we aimed to assess mTORC1 activity in reserve ISCs following 
calorie restriction.  
We used phosphorylation of ribosomal protein S6 (pS6) by the mTORC1 target S6 
Kinase as a readout for mTORC1 activity and, as previously reported (Morley and Traugh, 1990), 
calorie restriction repressed mTORC1 signaling under basal conditions (Figure 3.2B). A recent 
study reported that mTORC1 signaling is required during regeneration of the intestinal epithelium 
after DNA damaging injury, as repression of this pathway leads to failed tissue regeneration 
(Faller et al., 2015). Interestingly, despite their lower mTORC1 activity under basal conditions, 
calorie restricted mice were fully capable of robust mTORC1 activation in regenerative foci in 
response to radiation injury to an extent greater than their ad libitum-fed counterparts (Figure 
3.2C). We next confirmed that CR specifically represses mTORC1 in reserve ISCs by quantifying 
pS6 levels in FACS-sorted Hopx-CreER+ ISCs from HT mice (Figure 3.2D).  We also tested the 
ability of radiation damage to induce mTORC1 activity in reserve ISCs and, consistent with 
immunostaining results, found very low levels of pS6 in these cells in their resting, basal state.  
S6 phosphorylation was markedly induced in reserve ISCs 48 hours after radiation, a time where 
the first cell divisions are initiated in reserve ISCs after DNA damage-induced cell cycle arrest 
and repair is completed (Figure 3.2E and Yan et al., 2012). These data led us to hypothesize that 
dynamic regulation and expanded response range of mTORC1 activity in reserve ISCs in calorie 
restricted mice is a major contributing factor to the enhanced tissue regeneration observed after 
caloric restriction. 
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Precise control of mTORC1 activity is required for efficient tissue regeneration 
To further functionally validate our hypothesis, we tested the ability of Leucine, a 
branched chain amino acid known to be among the most potent nutrient agonists of the mTORC1 
complex in vitro (Fox et al., 1998), to activate mTORC1 in vivo. Western blotting of crypt extracts 
after 1.5% Leucine administration in the drinking water confirmed the ability of this amino acid to 
potentiate mTORC1 activity in vivo (Figure 3.3A). Next, we assessed the effect of mTORC1 
activation by Leucine, as well as mTORC1 inhibition by Rapamycin treatment, on lineage tracing 
from reserve ISCs 2 weeks after reporter activation in HT mice.  Leucine stimulation increased 
the number of tracing events from reserve ISCs and Rapamycin had the opposite effect, 
demonstrating the necessity and sufficiency of mTORC1 signaling for activation of reserve ISCs 
(Figure 3.3B). To assess whether the effect of mTORC1 modulation on reserve ISC activation 
was cell autonomous, we FACS-purified reserve ISCs and tested the outcome of adding Leucine 
or Rapamycin to the culture media on intestinal organoid formation from single cells. Consistent 
with our in vivo results, addition of Leucine increased the organoid formation efficiency, while 
Rapamycin had the opposite effect, indicating that mTORC1 activity regulates reserve ISC 
activation in a cell-autonomous manner (Figure 3.3C). Interestingly, the repressive effects of 
Rapamycin were significantly stronger that the inductive effects of Leucine, possibly due to the 
presence of high levels of potent ISC mitogens and known mTORC1 agonists in the culture 
media, including Wnt, Notch, and EGF ligands, as well as BMP antagonists, resulting in high 
basal levels of organoid formation in these cultures.   
To further confirm the cell-autonomous effect of modulation of mTORC1 on activation of 
reserve ISCs in vivo, we utilized mouse models to genetically activate mTORC1 specifically in 
Hopx-CreER+ reserve ISCs. We bred the Hopx-CreER::Rosa26LSL-tdTomato reporter alleles into 
mice harboring floxed alleles of Tsc1 (Tsc1flox/flox::Hopx-CreER::Rosa26LSL-tdTomato, THT mice) 
(Kwiatkowski et al., 2002). Consistent with our results using Leucine, we observed increases in 
lineage tracing events from reserve ISCs of THT mice 2 weeks after Hopx-CreER induction of 
reporter activity/Tsc1 deletion (Figure 3.3D). Conversely, inhibition of mTORC1 activity in reserve 
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ISCs via Raptor inactivation in Raptorflox/flox::Hopx-CreER::Rosa26LSL-tdTomato (RHT) mice 
abrogated regeneration 3 days after radiation injury (Figure 3.3E) confirming the functional 
importance of mTORC1-mediated regulation of reserve ISC activity in tissue regeneration.  
mTORC1 modulation regulates the intestinal response to high dose γ-IR Injury 
Finally, we asked whether inhibition of mTORC1 in reserve ISCs, as we observed in CR 
mice, has a radioprotective role at the time of injury. We assessed apoptotic cell death in reserve 
ISCs of mice that were treated with either Leucine or Rapamycin beginning 3 days prior to 
radiation exposure. Interestingly, inhibition of mTORC1 signaling prior to injury protected reserve 
ISCs against apoptosis, while stimulation of mTORC1 during this same period sensitized reserve 
ISCs to ionizing radiation (Figure 3.4A). We then assessed the effect of modulation of mTORC1 
prior to ionizing radiation exposure on the subsequent regenerative response. To this end, we 
activated mTORC1 signaling through administration of Leucine in drinking water starting 3 days 
prior to radiation injury and observed that premature activation of mTORC1 signaling impaired the 
epithelial regenerative response (Figure 3.4B).  
Taken together, our findings demonstrate that reserve intestinal stem cell-autonomous 
activity of mTORC1 plays a significant functional role in governing the regenerative response of 
the epithelium to DNA damaging injury and contributes to the beneficial effects of calorie 
restriction. 
 
Discussion 
There has been considerable interest in gaining a better understanding of the cellular 
basis underlying regeneration of the intestinal epithelium following DNA damage by radiation 
exposure, chemotherapy, microbiome dysbiosis, and ischemia-reperfusion injury, not only to 
enable strategies to targeting these cells to enhance regeneration, but also because of the 
apparent parallels between intestinal regeneration and oncogenic transformation.  
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Previous studies reported that calorie restriction improves regeneration of the intestinal 
epithelium following high dose γ-IR through a non-cell autonomous effect on actively cycling 
CBCs mediated by Paneth cells intercalated between CBCs (Yilmaz et al., 2012). Given that 
WntHigh/Lgr5High CBCs are quantitatively ablated by high dose γ-irradiation and that regeneration 
following radiation injury is mostly driven by surviving WntLow/Off  cells, the beneficial effects of 
calorie restriction are likely not limited to active Lgr5 CBCs and may rather reflect the activity of 
additional stem cell populations (Asfaha et al., 2015; Tao et al., 2015; Yan et al., 2012). This 
notion is further supported by recent data that Paneth cells, purported to be the niche for CBCs 
responsible for governing their activity, are actually dispensable for CBC function and for 
epithelial regeneration in response to high dose radiation injury(Durand et al., 2012; Kabiri et al., 
2014b; Kim et al., 2012; San Roman et al., 2014). 
Here, we show that radioresistant ISCs within Hopx-CreER-marked populations 
functionally contribute to the enhanced regenerative outcome following DNA damaging injury in 
CR mice. We demonstrate that calorie restriction suppresses mTORC1 signaling in these reserve 
ISCs and this, in turn, protects reserve ISCs against radiation injury. However, we and others 
have shown that potent activation of mTORC1 signaling and metabolic pathways are also 
required during regeneration following injury. Interestingly, despite the repression of mTORC1 in 
calorie restricted mice, the epithelium maintained the ability not only to activate mTORC1 in 
response to injury, but did so to an extent greater than that seen with ad libitum-fed animals. 
Curiously a similar phenomenon has been observed in the context of fasting, where Pten 
inactivation through phosphorylation poises reserve ISCs to contribute to epithelial regeneration 
upon feeding(Richmond et al., 2015). 
Ultimately, our findings emphasize the significance of precisely governed mTORC1 
activity in protecting stem cells against injury and driving them to expand and repopulate the 
tissue when called upon. The discovery of the role of mTORC1 signaling in controlling reserve 
intestinal stem cell activity provides a framework for future studies aimed at the development of 
pharmacological or dietary interventions that delay ISC activation in an effort to protect patients 
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against acute side effects of radiation therapy and radiation-induced acute gastrointestinal 
syndrome. 
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Figure 3. 1. Calorie restriction expands the pool of radioresistant reserve intestinal stem 
cells 
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Figure 3.1. Calorie restriction expands the pool of radioresistant reserve intestinal stem 
cells 
(A) Immunofluorescence staining for tdTomato (red) on jejunal sections from Hopx-
CreER::LSL-tdTomato ad libitum(AL) and calorie restricted(CR) mice 18 hours after a single 
Tamoxifen injection. Epithelial crypts are outlined by a white dash line. Scale bar=50 µm 
(B) Analysis of frequency of reserve ISCs in CR and AL Hopx-CreER::LSL-tdTomato and 
Bmi1-CreER::LSL-tdTomato mice using flow-cytometry, 18 hours after Tamoxifen injection (n=4-6 
for each condition, * p<0.05). 
(C)  Analysis of EdU incorporation in reserve ISCs and crypt cells of AL and CR Hopx-
CreER::LSL-tdTomato and Bmi1-CreER::LSL-tdTomato mice using flow-cytometry, 18 hours after 
Tamoxifen and 4 hours after EdU injections. The proliferation of CR groups is normalized to their 
control AL counterparts (n=4-6 for each condition, * p<0.05 and ***p<0.0005).  
(D) Immunofluorescence staining for tdTomato (red) and quantification of lineage tracing 
events (ribbons of tdTomato+ cells with contiguous tracing from crypts, through crypt-villus 
junction, and into villi) from Hopx-CreER+ ISCs 14 days after marking reserve ISCs with a single 
Tamoxifen injection to Hopx-CreER::LSL-tdTomato mice under AL and CR diets (n=4-6 for each 
condition, *p<0.05, scale bar= 100 μm). 
(E) Representative Ki67(red)-stained sections from jejunum of irradiated Hopx-CreER::LSL-
DTA  and their control counterparts (LSL-DTA) mice after 6 weeks of receiving CR or AL diet and 
quantification of number of proliferative crypt foci per unit length of small intestine. All groups of 
mice were given 3 daily consecutive doses of Tamoxifen and were exposed to 12Gy γ-IR 3 days 
after the last dose of Tamoxifen. Tissue was harvested 3 days after γ-IR (n=5 for each condition, 
***p<0.0005, scale bar=100 μm). 
 
	 47	
 
Figure 3. 2. mTORC1 activity is precisely regulated during the regenerative response of the 
intestinal epithelium following radiation injury 
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Figure 3.2. mTORC1 activity is precisely regulated during the regenerative response of the 
intestinal epithelium following radiation injury 
(A) Gene set enrichment analysis (GSEA) of the Hopx-CreER+ ISCs isolated from CR mice 
and AL mice.   
(B and C)   Immunofluorescence staining for pS6 (red) in the jejunum of CR and AL mice under 
basal conditions (pre-IR) and 3 days after radiation injury. The exposure time in figure 3.2 B is 
higher (5 seconds) that those in 3.2 C (1 second) in order to clearly highlight differences in pS6 
levels under basal conditions. scale bar=50 μm 
(D) Immunofluorescence staining for pS6 and quantification of pS6 fluorescence intensity in 
reserve ISCs from Hopx-CreER::LSL-tdTomato AL and CR mice, 18 hours after Tamoxifen 
induction. (n=30-40 ISCs from each of 2 mice in each group, **p<0.05, scale bar=5 μM). 
(E) Western blot analysis for pS6 in 21,000 FACS-purified reserve stem cells from Hopx-
CreER::LSL-tdTomato mice under basal conditions and 48 hours after irradiation injury.  Both 
groups were given Tamoxifen 18 hours before tissue harvest. 
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Figure 3. 3. mTORC1 modulates activation of reserve ISCs in a cell-autonomous manner 
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Figure 3.3. mTORC1 modulates activation of reserve ISCs in a cell-autonomous manner 
(A) Western blot analysis for pS6 in protein extracted from the intestinal epithelium of a 
cohort of mice that were fasted for 16 hours and then divided into two groups. One group was 
harvested after fasting and the other group received 1.5% Leucine in the drinking water for 6 
hours following fasting (n=3). 
(B) Lineage tracing from Hopx-CreER+ ISCs using immunofluorescence staining for 
tdTomato in sections from Hopx-CreER::LSL-tdTomato and control mice 2 weeks after Tamoxifen 
treatment (Scale bar =50μM). Rapamycin and Leucine treatments started 3 days before 
Tamoxifen injection and continued until time of harvest (n=2, scale bar= 100 um).  
(C) Organoid formation assays from single FACS-purified Hopx-CreER+ ISCs from Hopx-
CreER::LSL-tdTomato mice that received one dose of Tamoxifen 18 hours before tissue harvest. 
Sorted cells were treated with 10 uM Leucine or Rapamycin for 72 hours in culture (n=2, * p<0.05 
and **p<0.005). 
(D) Lineage tracing from reserve ISCs in Hopx-CreER::Tsc1flox/flox::LSL-tdTomato (THT) mice 
visualized with immunofluorescence staining for tdTomato in jejunal sections 2 weeks after 
Tamoxifen treatment (n= 5, *p<0.05, scale bar =100μm).  
(E) Quantification of regeneration efficiency of Raptorflox/flox::Hopx-CreER (RH)  and control 
mice following 12 Gy γ-IR. All groups received 3 consecutive doses of Tamoxifen and were 
irradiated 3 days after the last dose. Tissue was harvested 3 days after γ-IR (n=7, *p<0.05). 
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Figure 3. 4. Premature activation of mTORC1 sensitizes reserve ISCs to radiation injury 
and results in regeneration failure 
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Figure 3.4. Premature activation of mTORC1 sensitizes reserve ISCs to radiation injury and 
results in regeneration failure 
(A) Flow-cytometric analysis of apoptosis in reserve ISCs from Hopx-CreER::LSL-tdTomato 
mice by staining for cleaved Caspase 3, two hours after 12 Gy γ-IR. Rapamycin and Leucine 
treatments were started 3 days before the time of harvest, and all group were given a single 
Tamoxifen dose 18 hours prior to tissue harvest (n=2-7, *p<0.05).  
(B) Ki67 (red) staining and quantification of the regeneration efficiency after irradiation injury 
in mice receiving 1.5% Leucine in their drinking water 3 days before γ-IR and control groups. 
Arrowheads indicate regenerative crypt foci (n=3, **p<0.005, scale bar= 50 um). 
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Msi RNA binding proteins control reserve intestinal stem cell quiescence 
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Introduction 
Radiation-induced acute gastrointestinal syndrome is caused when the body is exposed 
to high doses of penetrating radiation (usually 10Gy or higher). Mortality rates are high in these 
instances, as destructive damage in the gastrointestinal (GI) tract results in electrolyte imbalance 
and rapid dehydration. The molecular determinants of intestinal radiosensitivity and GI syndrome 
are poorly understood. Intestinal stem cells (ISCs), which are crucial for physiological tissue 
homeostasis and regeneration after injury, are thought to play a critical role in this process 
(Ch’ang et al., 2005; Potten, 2004).  
Crypt base columnar (CBC) cells are highly proliferative stem cells that reside at the base 
of intestinal crypts. CBCs are characterized by high activity of the canonical Wnt pathway, and 
activity of the Wnt target gene Lgr5 is commonly used for their identification and prospective 
isolation (Barker et al., 2009; Cheng and Leblond, 1974). While CBCs are widely believed to 
maintain the daily proliferative burden of the high-turnover epithelium, they are sensitive to DNA 
damage-causing agents such as high dose gamma-irradiation (γ-IR), and several independent 
studies demonstrated that CBCs are largely ablated following γ-IR (Asfaha et al., 2015; Metcalfe 
et al., 2014; Yan et al., 2012). Recently, Tao et al. showed that high Wnt pathway activity and 
basal crypt positioning sensitize CBCs to DNA damage, leading to their preferential depletion 
(Tao et al., 2015).  Interestingly, this study also characterized a population of Wntlow/Lgr5low cells 
above the crypt base that appear more radioresistant, raising the possibility that the Lgr5-marked 
population is heterogeneous, and that Lgr5low cells may contribute to regeneration following 
irradiation. Another study showed that ablation of Lgr5-expressing cells by virtue of a diphtheria 
toxin receptor inserted into the endogenous Lgr5 locus activated shortly before (or after) 
administration of high dose radiation impairs the regeneration efficiency of the epithelium, 
suggesting a contribution from Lgr5+ cells to regeneration after radiation injury, although the 
timing of diphtheria toxin administration make it difficult to dissect the contribution of radio-
resistant versus de novo-generated Lgr5+ cells to the regenerative process (Metcalfe et al., 
2014).  
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Despite the loss of the vast majority of Wnthigh CBCs after high-dose γ-IR, regenerative 
crypt foci begin appearing approximately 2-3 days after γ-IR exposure and fully repair the 
epithelium within approximately 5 days. This regeneration is driven by a population of 
radioresistant stem cells with little to no canonical Wnt pathway activity (referred to hereafter as 
“reserve ISCs”). At least some of these reserve ISCs can be marked by CreER reporter genes 
targeted to the endogenous Bmi1 and Hopx loci(Li et al., 2014; Sangiorgi and Capecchi, 2008; 
Takeda et al., 2011; Yan et al., 2012), however recent evidence also suggests that more 
differentiated cells may also act as facultative stem cells upon ablation of CBCs (Tetteh et al., 
2016). Despite the lack of consensus on the precise population(s) contributing to regeneration 
after injury, clear evidence demonstrates that under basal conditions in the absence of injury 
Bmi1-/Hopx-CreER-marked reserve ISCs give rise to CBCs.  Lineage tracing coupled with single 
cell gene expression profiling reveals that Bmi1-/Hopx-CreER alleles mark a largely overlapping 
population of Wntoff reserve ISCs that give rise to active, Wnthigh Lgr5+ CBCs upon division, and 
consequently all functional cell types of the epithelium over long periods of time (Li et al., 2014; 
Takeda et al., 2011; Tian et al., 2011; Yan et al., 2012). Unlike Lgr5+ CBCs, the population of 
reserve ISCs is largely quiescent (in G0 and metabolically inactive) rather than activated 
(metabolically active and within the cell cycle) (Li et al., 2016c). It has been postulated that the 
low metabolic activity of quiescent stem cells discourages genetic lesions induced by reactive 
oxygen species (Pazhanisamy, 2009). However, knowledge of the molecular mechanisms 
governing their radioresistance and subsequent exit from the quiescent state in response to γ-IR 
injury is lacking.  
Musashi (Msi) RNA-binding proteins are expressed in the stem cell compartments of 
several tissues including the brain, intestine, and blood, and are upregulated in cancers arising 
from these tissues (Li et al., 2015; Park et al., 2014; Wang et al., 2015). Msi proteins act primarily 
as translational regulators binding to messenger RNAs, and known target transcripts are involved 
in the regulation of cell cycle progression, metabolism, and stem cell self-renewal (Li et al., 2015; 
Park et al., 2014; Wang et al., 2015). In the hematopoietic system, Msi2 is an important 
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modulator of long-term hematopoietic stem cell (LT-HSC) proliferation and self-renewal (Hope et 
al., 2010; Ito et al., 2010; Kharas et al., 2010; Park et al., 2014). Ectopic induction of Msi2 
increases LT-HSC numbers, which is associated with a reduction in stem cell quiescence and a 
concomitant increase in the percentage of actively cycling LT-HSCs (Kharas et al., 2010). 
Conversely, Msi2 deletion results in loss of engraftment potential of LT-HSCs in transplantation 
assays, demonstrating the importance of Msi2 in this largely dormant stem cell population (Park 
et al., 2014). 
In the intestinal epithelium, Msi proteins are expressed throughout the crypt, including in 
the active CBC stem cell compartment (Itzkovitz et al., 2011; Li et al., 2014, 2015; Wang et al., 
2015). We have previously established that Msi proteins are obligate and functionally redundant 
intestinal oncoproteins that drive epithelial transformation in large part through inhibition of 
intestinal tumor suppressors including Pten resulting in downstream mTORC1 complex activation 
(Li et al., 2015; Wang et al., 2015); however, their role in intestinal homeostasis, regeneration, 
and stem cell self-renewal in vivo is entirely unknown.  
Here, we establish that Msi proteins are dispensable for the Wnt-driven self-renewal of 
CBCs, but are required for cell cycle entry of quiescent reserve ISCs.  Msi upregulation in reserve 
ISCs is sufficient to induce expression of metabolic genes including Myc, H6pd, and Hif1α and 
drive exit of reserve ISCs from G0 and into the cell cycle. Conversely, genetic ablation of Msi 
genes abrogates cell cycle entry.  This manifests phenotypically in the failure of epithelial 
regeneration in response to injury. Further, we demonstrate that Msi expression must be tightly 
regulated in quiescent ISCs, as premature Msi induction prior to γ-irradiation injury sensitizes the 
intestinal epithelium to injury and impairs regenerative capacity. This emphasizes the importance 
of maintaining a pool of quiescent stem cells in order for the tissue to mount an effective injury 
response.  
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Results 
Msi activity is dispensable for intestinal homeostasis, Wnt pathway activity, and CBC 
function under basal conditions 
We initially confirmed published reports of Msi expression in the intestinal crypt, where 
Msi1 and Msi2 are expressed in CBCs and in the transit-amplifying zone (Figure 4.1A and (Li et 
al., 2015)).  To unequivocally test the functional contribution of Msi proteins to intestinal 
homeostasis and stem cell self-renewal, we intercrossed Msi1 and Msi2 conditional knockout 
alleles previously generated in our laboratory (Katz et al., 2014; Li et al., 2015; Park et al., 2014; 
Wang et al., 2015) with mice harboring a Villin-CreER transgene that drives robust, inducible 
recombination throughout all epithelial cells in the small intestine and colon (Li et al., 2015; el 
Marjou et al., 2004). Ablation of either Msi1 or Msi2 individually throughout the intestinal 
epithelium and colon had no effect on tissue homeostasis, proliferation, or differentiation (not 
shown), consistent with published studies demonstrating their functional redundancy (Li et al., 
2015; Sakakibara et al., 2002).  
We therefore examined the consequences of concomitant ablation of both Msi1 and Msi2 
in Msi1flox/flox::Msi2flox/flox::Villin-CreER double knockout (MsiDKO) mice. We followed MsiDKO 
mice for one week and up to 6 months after deletion and, surprisingly, observed no overt 
phenotypic changes to intestinal crypt-villus architecture (Figure 4.1B) or alteration in proliferation 
(Figure 4.1C, 4.2A) or differentiation based on the frequency of Paneth and Goblet cells (Figure 
4.2B, C). We also examined the colon in MsiDKO and control mice and similarly observed no 
phenotypic changes (Figure 4.3A, B) or alteration in proliferation (Figure 4.3C).  
Transcriptome profiles from the crypts of control and MsiDKO mice 1 week after Msi 
deletion with Villin-CreER showed little differential gene expression, consistent with the 
phenotypic analysis. The few genes with significant changes in expression (fold change ≥1.5, p-
value ≤ 0.1) were not enriched for any specific functional ontology (Table 4.1). Importantly, loss of 
Msi activity had no deleterious consequences for expression of Wnt pathway target genes, which 
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are critical for proper intestinal homeostasis and CBC proliferation (Figure 4.1D). In addition, 
ablation of Msi1, Msi2, or both had no effect on nuclear localization of the Wnt transcriptional 
effector β-catenin in cells at the crypt base (Figure 4.3D). Further, we were able to generate Msi-
null crypt organoids in vitro and passage them serially with no decrease in organoid forming 
efficiency or detectable increase in Msi expression expected to result from selective pressure if 
rare cells escaping recombination had a growth advantage (Figure4.1E and 4.3E). There was 
also no difference in organoid formation efficiency between MsiDKO and control crypts at any R-
spondin concentration tested in the absence of GSK-3 inhibitor (Figure 4.1E). These findings 
demonstrate that Msi does not support activity of the canonical Wnt pathway, and this is in 
contrast to in vitro studies and in vivo gain of function assays suggesting that Msi potentiates 
activity of this pathway. 
Ultimately, we tested the effects of Msi loss on the activity of CBCs marked by an Lgr5-
eGFP-CreER reporter allele (Barker et al., 2007). Msi loss had no effect on the frequency or 
proliferation of CBCs (Figure 4.3F, G). In addition, lineage tracing in Lgr5-eGFP-
CreER::Msi1flox/flox::Msi2flox/flox::R26-Lox-Stop-Lox-tdTomato or control (Lgr5-eGFP-CreER::R26-
Lox-Stop-Lox-tdTomato) mice demonstrates that Msi loss has no detrimental consequences for 
CBC stem cell activity in vivo, either in the small intestine or colon (Figure 4.1F, 4.3H). We 
confirmed efficient deletion of Msi1/2 in Lgr5+ ISCs and their progeny (Figure 4.3I, J).  
Taken together, these findings demonstrate that Msi loss has no effect on the activity of 
the canonical Wnt pathway or the proliferative self-renewal of crypt base columnar stem cells. 
 
Msi proteins are required for intestinal regeneration following radiation injury 
Given prior findings demonstrating that Msi1/2 activity potentiates the activity of the 
mTORC1 complex in colorectal cancer (Li et al., 2015; Wang et al., 2015)  and that mTORC1 is 
similarly dispensable for intestinal homeostasis, but is required for epithelial regeneration in 
response to injury (Ashton et al., 2010; Faller et al., 2015), we next sought to determine how Msi 
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loss affects intestinal regeneration in response to radiation injury.  Msi1flox/flox::Msi2flox/flox::Villin-
CreER or control Msi1flox/flox::Msi2flox/flox mice were treated with 5 daily doses of Tamoxifen, and 
subjected to 12 Gy  of ionizing gamma-irradiation (γ-IR) one week later to ablate proliferative cells 
including CBCs (Tao et al., 2015; Tian et al., 2011).  In this context, intestinal regeneration 
(quantified by the number of clonal regenerative crypt foci per unit length, 72 hours after injury) 
was severely compromised in the absence of Msi activity (Figure 4.4A, 4.5A). No differences in 
the distribution of residual differentiated cell types were observed (Figure 4.5B, C). Any 
regenerative crypt foci observed in Msi1flox/flox::Msi2flox/flox::Villin-CreER mice were found to have 
escaped recombination at one or more of the floxed Msi alleles (Figure 4.4B).  These data 
demonstrate that Msi activity is necessary for regeneration of the epithelium 
Recent studies indicate that the regenerative capacity of the epithelium in response to 
such high-dose γ-IR resides in a population of reserve intestinal ISCs that are marked, at least in 
part, by Hopx-CreER or Bmi1-CreER alleles (and possibly by other proxy reporter alleles) (Asfaha 
et al., 2015; Metcalfe et al., 2014; Montgomery et al., 2011; Takeda et al., 2011; Yan et al., 2012).  
Bmi1- or Hopx-CreER reporters are known to mark a largely overlapping population of rare 
reserve ISCs (although the Hopx-CreER population is more homogenous) (Li et al., 2014).  We 
next asked, therefore, whether Msi ablation specifically in this rare reserve ISC population could 
account for the failed regenerative response we observed after Msi ablation throughout the 
epithelium using Villin-CreER.  To address this, we crossed the Hopx-CreER allele into the 
Msi1flox/flox::Msi2flox/flox mice and assessed regeneration of intestinal epithelium after deletion of Msi 
using Villin-CreER, Hopx-CreER or Lgr5-CreER and exposure to 12Gy γ-IR. Msi ablation with 
Lgr5-CreER had no significant effect on regeneration, although a modest, non-significant 
decrease in regeneration was observed, possibly reflecting the function of an Lgr5Low cell 
previously described as radioresistant (Tao et al., 2015). In contrast, Msi loss in rare Hopx-CreER 
reserve ISCs (making up less than 0.5% of the crypt epithelium (Li et al., 2014; Takeda et al., 
2011)), and some of their immediate progeny (as some reserve ISCs must divide during the time 
required for multiple Tamoxifen injections prior to irradiation) resulted in failed epithelial 
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regeneration to an extent indistinguishable from that observed with pan-epithelial Villin-CreER 
deletion, highlighting the importance of these rare reserve ISCs in the regenerative response of 
the intestinal epithelium (Figure 4.4C).  
 
Msi activity selectively governs reserve stem cell proliferation 
While these findings demonstrate that Hopx-/Bmi1-CreER reserve ISCs are important for 
epithelial regeneration after injury, recent data also suggests that the more differentiated progeny 
of Lgr5+ CBCs can revert to the CBC state and reacquire stem cell activity after CBC ablation with 
diphtheria toxin (Tetteh et al., 2016).  Under basal, non-injury conditions, Hopx-/Bmi1-CreER 
ISCs are known to give rise to Lgr5+ CBCs upon division (Li et al., 2014; Takeda et al., 2011; Tian 
et al., 2011).  We thus sought to examine if Msi plays an important role in the activation of these 
reserve ISCs during basal homeostasis.  We initially performed single cell gene expression 
analysis in Lgr5+ CBCs, in reserve ISCs, and in the progeny of reserve ISCs after 4 days of 
lineage tracing.  As predicted, in the resting state reserve ISCs marked by Hopx-/Bmi-
CreER::R26-Lox-Stop-Lox-tdTomato reporter activity 18 hours after a single Tamoxifen dose (Li 
et al., 2014; Takeda et al., 2011) express low levels of Msi genes and exist in a WntOff/Low state, 
with little to no expression of canonical Wnt targets such as Lgr5, Ascl2 and Ccnd1 along with 
high levels of the cell cycle inhibitor Cdkn1a, in stark contrast to CBCs (Figure 4.6A, B).  Four 
days after initiation of lineage tracing (a time point at which about half of reserve ISCs have 
divided to form clusters of 2 or more daughter cells (Li et al., 2014; Takeda et al., 2011)), reserve 
ISC progeny began activating Msi genes and canonical Wnt target genes (Figure 4.6B).  These 
data further suggest that Msi activity plays a role in promoting reserve ISC cell cycle entry.  
To test this definitively, we examined lineage tracing from control mice (Hopx-/Bmi1-
CreER::R26-Lox-Stop-Lox-tdTomato) or mice in which Msi activity is ablated specifically in 
reserve ISCs (Msi1flox/flox::Msi2flox/flox::Hopx-/Bmi1-CreER::R26-Lox-Stop-Lox-tdTomato). As 
predicted based on previous reports and single cell gene expression analysis (Figure 4.6B), 
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reserve ISCs in control mice gave rise to clonal lineage tracing events that encompassed the 
entire crypt-villus axis after 14 days.  In contrast, Msi loss abrogated lineage tracing from reserve 
ISCs, and these cells remained as single labeled cells within intestinal crypts 14 days after 
initiation of tracing (Figure 4.6C, arrowheads). Thus, these findings demonstrate that Msi activity 
is required for reserve ISC activation under basal homeostatic conditions where these cells 
normally generate CBCs. 
 
Reserve ISCs represent a quiescent stem cell pool residing in G0 and require Msi activity 
for S-phase entry 
Recent findings that high Wnt pathway activity and cell cycling render CBCs susceptible 
to DNA damage (Tao et al., 2015) support a model in which a more dormant pool of reserve stem 
cells remains injury-resistant to regenerate the epithelium after damage.  These reserve stem 
cells are often referred to as quiescent (i.e., residing in the G0 state outside of the cell cycle).  We 
therefore sought to characterize quiescence in reserve ISCs.  In stem cell biology, quiescence 
usually refers to cells with a dormant genome and low metabolic activity, reflected by low RNA 
levels in a diploid cell (G0), rather than simply the absence of cycling, which can also result from 
G1 arrest (Fukada et al., 2007; Hüttmann et al., 2001).  We first examined reserve ISC 
populations marked by Hopx-/Bmi1-CreER::R26-Lox-Stop-Lox-tdTomato and found that the 
majority of these populations reside in G0 (Figure 4.7A).  Exposure of these mice to 12 Gy γ-IR 
resulted in an exit of reserve ISCs from G0 and into the cell cycle concomitant to an increase in 
Msi (Figure 4.7B, C and 4.8A, B), consistent with the previous functional demonstration that Msi 
activity in these cells is important for effective regeneration. We next asked how Msi loss affected 
the quiescent status of the reserve ISC compartment.  Interestingly, ablation of Msi in reserve 
ISCs resulted in a G1, not G0 arrest (Figure 4.7D). Further, these cells were no longer able to 
enter S-phase and incorporate EdU in response to 12 Gy γ-IR (Figure 4.7D, E). Interestingly, 
these findings are consistent with previous studies on the mTORC1 complex, inactivation of 
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which similarly results in a G1 arrest (Kalaitzidis et al., 2012) as well as a failure of the intestinal 
epithelium to regenerate in response to high dose γ-IR injury (Ashton et al., 2010; Faller et al., 
2015). 
Taken together, the findings thus far demonstrate that reserve ISCs represent a pool of 
quiescent stem cells that require induction of Msi activity for proper exit from quiescence and cell 
cycle entry which, in turn, is necessary for regeneration of the epithelium in response to injury. 
 
Msi activity is sufficient to drive reserve ISCs out of G0 and into the cell cycle 
We next asked whether Msi activity alone was sufficient to drive reserve ISC exit from G0 
and into the cell cycle.  For this we employed a mouse model in which a single copy of Msi1 is 
targeted into safe-haven chromatin and is under control of the doxycycline (Dox)-inducible 
tetracycline responsive element (TRE-Msi1) (Li et al., 2015). Administration of Dox to Hopx-
/Bmi1-CreER::R26-Lox-Stop-Lox-tdTomato::TRE-Msi1 mice for as little as 36 hours resulted in 
robust exit of reserve ISCs from G0 and subsequent entry into the cell cycle (Figure 4.9A). This 
ectopic Msi induction drove increased proliferation and lineage tracing from reserve ISCs (Figure 
4.9B-D).  At the molecular level, Msi induction activated expression of metabolic and proliferative 
genes such as H6pd, Hif1α, and c-Myc in reserve ISCs (Figure 4.9E and 4.10A). In contrast, 
ectopic Msi induction did not induce expression of canonical Wnt target genes such as Lgr5 and 
Ascl2 in reserve ISCs (Figure 4.9 E).  Further, ectopic Msi induction had no effect on the 
molecular identity of CBCs, further confirming the cell type specificity of Msi function (Figure 4.9E, 
F). These findings indicate that Msi drives reserve stem cells out of quiescence in a Wnt-
independent manner. 
 
Premature exit of reserve ISCs from G0 sensitizes the intestinal epithelium to radiation 
injury 
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Ultimately, the data presented thus far lead to a model in which reserve ISCs maintain 
radioresistance by virtue of their residence in the quiescent G0 state outside of the cell cycle in 
the absence of Msi activity.  Under basal conditions, Msi is periodically activated in reserve ISCs, 
enabling their exit from quiescence.  Upon Msi ablation these cells can no longer enter the cell 
cycle, and the activity of CBCs (which do not require Msi activity) masks any phenotypic 
consequences of failed reserve ISC activation.  Only upon radiation injury and CBC ablation do 
the phenotypic consequences of Msi loss and failed reserve ISC activation manifest themselves 
as failed epithelial regeneration. 
If this model were correct, we would predict that premature exit of reserve ISCs from G0 
and into the cell cycle should sensitize these cells and the intestinal epithelium to radiation 
damage, resulting in failed regeneration.  To test this, we drove reserve ISCs out of G0 with a 24-
hour pulse of ectopic Msi1 induction in TRE-Msi1 mice followed by exposure to 12 Gy γ-IR injury 
and quantified the frequency of clonal regenerative crypt foci.  Indeed, in this context the 
regenerative capacity of the epithelium was severely compromised (Figure 4.12A), providing 
support to the notion that maintenance of a pool of reserve ISCs in G0 acts as protective 
mechanisms for the tissue in the event of DNA damage. In contrast, Dox administration and Msi 
induction 48 hours after γ-IR had no deleterious effects on regeneration of TRE-Msi1 mice 
(Figure 4.10B). 
 
mTORC1 activation is sufficient to rescue the impaired in Msi-DKO mice after high-
dose irradiation 
We have recently shown that mTORC1 activity is strongly potentiated in the intestinal 
epithelium in response to forced Msi expression in vivo, and that endogenous Msi directly binds 
to several transcripts encoding known negative regulators of mTORC1, including Pten, Lrig1, and 
Bmpr1a (Li et al., 2015; Wang et al., 2015). Interestingly, the lack of phenotype in MsiDKO mice 
is consistent with that of mTORC1 inactivation during intestinal homeostasis (Ashton et al., 2010; 
	 64	
Faller et al., 2015), and the G1 arrest we observed in reserve ISCs has previously been observed 
in response to mTORC1 inactivation in the hematopoietic system (Kalaitzidis et al., 2012). We 
therefore set out to assess potential regulation of mTORC1 by Msi proteins in reserve ISC. 
Dox-induction of Msi1 in the TRE-Msi1 mouse for 36 hours followed by purification of 
Bmi1 or Hopx- ISCs revealed that Msi1 was sufficient to activate mTORC1 activity in these cells 
(Figure 4.11A). Next, we tested whether the previously observed interaction of Msi to transcripts 
encoding negative regulators of mTORC1 occurs specifically in reserve ISCs. We observed a 
significant increase of Msi1 binding to Pten mRNA upon Msi1 induction (Figure 4.11 B). We also 
observed Msi1 binding to Lrig1 and Bmpr1a mRNA (data not shown), however this binding did 
not increase in a statistically significant manner upon Msi1 induction. This further suggests that 
mTORC1 activation downstream of Msi-Pten mRNA interaction might promote ISC activation.  
In response to 12 Gy γ-IR, Msi and mTORC1 activity were markedly increased in 
regenerative crypt foci (Figure 4.8 C and Figure 3.2E). To assess whether Pten links Msi 
upregulation following radiation to mTORC1 activation, we assessed level of Phosphatidylinositol 
(3,4,5)-trisphosphate (PIP3) after IR in reserve ISCs and observe an increase in the fluorescence 
intensity of PIP3 staining after IR, at the same time that Msi is upregulated (Figure 4.7 C and 4.11 
C). PIP3 is the product of phosphatidylinositol-3 kinase (PI3K) and the main substrate for Pten 
phosphatase activity.  Pten function antagonizes the PI3K signaling pathway by converting PIP3 
to phosphtidylinositol 4,5-biphosphate (PIP2). Increased production of PIP3 or suppression of 
Pten leads to recruitment of Akt to the membrane and activation of Akt-mTORC1 signaling axis 
(Vazquez and Devreotes, 2006). Taken together, these data are consistent with a model in which 
Msi interaction with the Pten mRNA inhibits Pten, leading to PIP3 accumulation and downstream 
activation of the Akt-mTORC1 axis to drive reserve ISCs out of quiescence. 
We have shown that Leucine stimulation activates mTORC1 signaling in vivo (Figure 3.3 
A). Thus, we evaluated the effect of Leucine on regeneration in the absence of Msi throughout 
the epithelium using Msi1/2flox/flox::Villin-CreER mice. We initially tested the effect of Leucine 
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administration (1.5% in drinking water) on regeneration efficiency following 12Gy γ-IR. 
Interestingly, Leucine administration 36 hours after γ-IR had no deleterious effects on 
regeneration of wild-type mice indicating that young healthy mice are capable of activating 
mTORC1 signaling at an optimal level during tissue regeneration (Figure 4.11 D). However, 
Leucine stimulation alone was sufficient to compensate for the loss of Msi activity and fully rescue 
the impaired regeneration of the intestinal epithelium (Figure 4.11 E). Taken together, these data 
provide compelling evidence that mTORC1 activation downstream of Msi1/2 activity is both 
necessary and sufficient for activation of quiescent reserve intestinal stem cells and their ability to 
regenerate the intestinal epithelium after high-dose γ-IR injury. 
 
Discussion 
It is becoming increasingly clear that several tissues in adult mammals, most notably the 
hematopoietic system, bifurcate their stem cell compartments into a slow cycling, quiescent stem 
cell capable of giving rise to a cycling, active stem cell (Li and Clevers, 2010). The benefit of such 
an organizational structure is the capacity to promote tissue regeneration after damage while 
maintaining the proliferative output necessary to keep up with the demands of high-turnover 
tissues using a relatively small stem cell pool. 
In the intestinal epithelium, recent studies have begun to define a hierarchical stem cell 
organization similar to what has been observed in the hematopoietic system, with a 
radioresistant, slow cycling reserve ISC giving rise to an actively proliferating crypt base columnar 
cell, whose self-renewal is driven by high Wnt pathway activity (Asfaha et al., 2015; Li and 
Clevers, 2010; Li et al., 2014; Montgomery et al., 2011; Takeda et al., 2011; Tian et al., 2011). 
There has been considerable interest in gaining a better understanding of radioresistant intestinal 
cells that contribute to regeneration following damage by radiation/chemo- therapy because of its 
relevance in the context of traditional cancer therapies, and also because of the apparent 
parallels between regeneration after damage and intestinal oncogenic transformation.  
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Recently, we have demonstrated that the Msi2 RNA binding protein is capable of driving 
long-term hematopoietic stem cells out of quiescence and into the cell cycle (Kharas et al., 2010). 
In the intestinal epithelium Msi1 and Msi2 function redundantly by binding to a number of 
transcripts that encode known negative regulators of mTORC1, including Pten, Bmpr1a, and 
Lrig1, and aberrant Msi activation leads to Pten repression and induction of the Akt-mTORC1 axis 
(Li et al., 2015; Wang et al., 2015).  
In the current study, we investigated the function of the Msi family of RNA-binding 
proteins in intestinal stem cell function under basal conditions and during regeneration in 
response to injury.  The data demonstrate that Msi1 and Msi2 are upregulated during the exit of 
reserve ISCs from quiescence, both under basal conditions and during regeneration after ablation 
of WntHigh CBCs in response to high dose radiation (Figure 4.12B).  We therefore tested the 
sufficiency and necessity of Msi proteins for reserve stem cell activation and CBC self-renewal. 
Remarkably, genetic ablation of either Msi family member, as well as concomitant ablation of both 
Msi1&2 throughout the intestinal epithelium and colon had no adverse effects on homeostasis, 
active CBC self-renewal, or Wnt pathway target gene expression, despite the high level of both 
Msi family members in the WntHigh CBC stem cells (Li et al., 2015; Maria Cambuli et al., 2013; 
Potten, 2004; Wang et al., 2015). 
In contrast to the lack of phenotype in crypt base columnar stem cells, Msi loss in of 
reserve ISCs (marked either by Hopx-CreER or Bmi1-CreER) resulted in the failure of these cells 
to become activated and contribute progeny to the epithelium. This failure of reserve ISC 
activation had no apparent detrimental consequences for the epithelium in the basal state, at 
least across the time period we investigated, likely due to the unaffected CBC compartment 
providing the proliferative output necessary for epithelial maintenance.  However, when mice 
lacking Msi activity either in the entire epithelium, or specifically in the very rare reserve ISCs, 
were exposed to DNA damaging γ-IR injury at levels known to ablate the CBC compartment, 
intestinal regeneration failed.  This finding highlights the importance of these rare reserve ISCs in 
mounting a regenerative response in the face of injury.  
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When considering how reserve ISCs resist DNA damage, we analyzed their cell cycle 
status.  Reserve ISCs are often referred to as being quiescent, or residing in G0, as this state is 
thought of as being protective to stem cells in unfavorable environments (Cheung and Rando, 
2013). Indeed, we observed that the majority of ISCs marked by Hopx-CreER or Bmi1-CreER 
reside in G0, while the remainder of the population cycles actively. We demonstrate that Msi 
activity controls the exit of reserve ISCs from the G0 state and their subsequent entry into the cell 
cycle.  The importance of maintaining a pool of quiescent stem cells as a means to respond to 
injury can be observed in gain of function experiments in which ectopic activation of Msi1 drives 
reserve ISCs from quiescence.  In this context, promiscuous exit of this population from G0 and 
into the cell cycle renders the epithelium susceptible to radiation injury, supporting the notion that 
residence in G0 protects ISCs from DNA damage. 
Interestingly, the phenotype of Msi loss of function is reminiscent of inactivation of 
mTORC1- both result in failed intestinal regeneration after injury and in a G1 cell cycle arrest 
(Ashton et al., 2010; Faller et al., 2015; Kalaitzidis et al., 2012). We have previously established 
that in the context of colorectal cancer mTORC1 is a functionally important target of Msi activity, 
and both mTORC1 and Msi are required for transformation of the epithelium downstream of APC 
loss.  Consistent with our current findings, a recent study found that the negative regulator of 
mTORC1 activity, Pten, regulates the proliferation of intestinal stem cells marked with proxy 
reporter alleles driven by the mTert promoter (a population that likely overlaps with the Hopx-
/Bmi1-CreER-marked population in the current study based on their functional and molecular 
similarities) (Richmond et al., 2015). These findings are entirely consistent with observations in 
the hematopoietic and muscle tissues, where mTORC1 similarly governs stem cell quiescence 
(Kalaitzidis et al., 2012; Rodgers et al., 2014). 
Taken together, our findings emphasize the significance of precise regulation of reserve 
stem cell quiescence in protecting the intestinal epithelium from genotoxic insults. The discovery 
that Msi proteins govern reserve intestinal stem cell activation provides a foundation for future 
studies aimed at the development of therapeutic interventions that delay ISC cell cycle entry in an 
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effort to protect patients against acute side effects of radiation therapy and radiation-induced 
acute gastrointestinal syndrome. 
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 Figure 4. 1. Msi activity is dispensable for intestinal homeostasis, Wnt pathway activity, 
and CBC function under basal conditions 
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Figure 4.1.  Msi activity is dispensable for intestinal homeostasis, Wnt pathway activity, 
and CBC function under basal conditions 
Msi1/2flox/flox::Villin-CreERT2 (MsiDKO) and control mice were given 5 consecutive daily doses of 
Tamoxifen and harvested either one week or 6 months later (n=3-5). 
(A) Msi1 and Msi2 staining in normal intestinal crypts under basal conditions in control and Msi-
DKO mice. Scale bar=50μM.  
(B) Hematoxylin and eosin (H&E) stained sections from the jejunum of mice described above, 6 
months after Tamoxifen injection and quantification of number of crypts per unit length of small 
intestine, and length of villi based on these H&E stained sections. Scale bar=100 μM. 
(C) Ki67 staining of sections from jejunum of mice described above and measurement of length of 
proliferative zone based on these Ki67-stained sections. Scale bar=50μM 
 (D) Gene expression analysis of Wnt pathway target genes of crypts isolated from 
Msi1/2flox/flox::Villin-CreER and control mice 1 week after Tamoxifen treatment (n=3).  
(E) Organoid formation assay with crypts isolated from Msi1/2flox/flox::Villin-CreER and control mice 
cultured with increasing doses of R-spondin in the absence of GSK-3 inhibitor. 50 crypts are 
initially plated per well (n=3). Scale bar=50μM 
 (F) Immunofluorescence staining for tdTomato in sections of small intestine and colon of Lgr5-
eGFP-IRES-CreER::LSL-tdTomato::Msi1/2flox/flox mice and their control counterparts 14 days after 
activating the tdTomato reporter and deleting Msi genes with Tamoxifen. Scale bar =50um. 
All data are expressed as mean +/- s.d. (* p<0.05, **p<0.005, ***p<0.0005, Student’s t test). 
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Figure 4. 2. Msi loss does not affect proliferation and differentiation of epithelial cells in 
the intestine under basal conditions 
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Figure 4.2. Msi loss does not affect proliferation and differentiation of of epithelial cells in 
the intestine under basal conditions. 
Msi1/2flox/flox::Villin-CreER and control mice were given 5 consecutive daily doses of Tamoxifen 
and harvested either one week or 6 months after the last dose (n=3-5). Scale bar=1000 μm 
(A) EdU and Lyzozyme co-staining on Swiss rolls of the small intestines of mice described 
above (left) and higher magnification of EdU staining of the same sections (right). Scale 
bar =100μM. 
(B) Lysozyme (Lyz) staining of sections from jejunum of mice described above and 
quantification of number of Paneth cells per crypt based on these sections. Scale 
bar=100 μm. 
(C) Alcian blue staining of sections from small intestine of mice described above and 
quantification of number of goblet cells per Villus based on these sections. Scale bar=100 
μm. 
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Figure 4. 3. Msi loss does not affect homeostasis of intestinal epithelium under basal 
conditions 
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Figure 4.3. Msi loss does not affect homeostasis of intestinal epithelium under basal 
conditions. 
(A) H&E stained sections from colon of mice as described in Figure 4.2, one week after 
Tamoxifen treatment, and measurement of number of colonic crypts per unit length in 
these sections. Scale bar=200 μm.  
(B) Measurement of depth of colonic crypts in sections described above. 
(C) Proliferative zone length quantification based on Ki67-stained sections from colon of mice 
described above one week after 5 daily Tamoxifen treatments. Data are expressed as 
mean +/- s.d. 
(D) Nuclear β-catenin staining of sections from jejunum of mice described above one week 
after 5 daily doses of Tamoxifen. Scale bar=100 μm. 
(E) Organoid formation assays and gene expression analysis of Msi1 and Msi2 over 4 serial 
passages of organoids isolated from mice described in (A) (n=3). Residual Msi2 
expression is likely from transcript read-through downstream of the deleted exons.  This 
residual transcript is frame-shifted and non-functional. Scale bar=50 μm. 
(F) Flow cytometric analysis of the frequency of Lgr5-eGFP+ CBCs in Lgr5-eGFP-IRES-
CreER::Msi1/2floxl/flox mice treated with 3 doses of Tamoxifen, 24 hours apart, and 
harvested 3 days after the last dose (n=3-4). 
(G) Flow cytometric analysis of EdU incorporation of Lgr5+ CBCs in mice described in (F) 
(n=3-4). 
(H) Quantification of lineage tracing from Lgr5-eGFP-IRES-CreER+ CBCs.  The percentage 
of crypts harboring marked cells upon Tamoxifen-induced Lgr5-eGFP-IRES-CreER::LSL-
tdTomato recombination that also lead to lineage tracing events into the villi were 
quantified based on 13-20 random microscopic fields of jejunum of Lgr5-eGFP-IRES-
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CreER::LSL-tdTomato::Msi1/2flox/flox mice and their control counterparts 14 days after 
activating the tdTomato reporter and deleting Msi genes with single dose of Tamoxifen. 
Confirmation of Msi deletion in subsequent panels I and J. 
(I) Assessing Msi deletion in Lgr5-eGFP-IRES-CreER::LSL-tdTomato::Msi1/2flox/flox mice by 
PCR on DNA extracted from FACS-purified tdTomato+ cells. In the Msi1-2lox and Msi2-
2lox PCR reactions, the positive control lane is derived from DNA from a Msi flox/wt:: 
Msiflox/wt  animal, and thus the upper band indicates the 2lox (Floxed) allele and the lower 
band indicates the wild-type allele. In Msi2 1-lox PCR, the band indicates the null allele. 
(J) Gene expression analysis of Msi1 and Msi2 in Lgr5-eGFP-IRES-CreER::LSL-
tdTomato::Msi1/2flox/flox CBCs 2 weeks after initiation of lineage tracing in mice described 
in (I). RNA was extracted from Tomato+/eGFP+ cells. Residual Msi2 expression is likely 
from transcript read-through downstream of the deleted exons.  This residual transcript is 
frame-shifted and non-functional. 
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Figure 4. 4. Msi loss abrogates epithelial regeneration following γ-IR injury 
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Figure 4.4. Msi loss abrogates epithelial regeneration following γ-IR injury 
(A) Representative Ki67-stained sections from jejunum of irradiated Msi1/2flox/flox::Villin-CreER and 
control mice and quantification of number of proliferative crypt foci per unit length of small 
intestine. All groups of mice were given 5 daily consecutive doses of Tamoxifen and were 
exposed to 12Gy γ-IR one week later. Tissue was harvested 3 days after γ-IR (n=5-6). Scale 
bar=100μM 
(B) Msi1 stained sections from jejunum of mice described in (A) and quantification of percentage 
regenerative crypts escaping recombination based on Ki67- and Msi- (Msi1/2) stained serial 
sections. 
(C) Msi1/2flox/flox::Villin-CreER,  Msi1/2flox/flox::Hopx-CreER, and  Msi1/2flox/flox::Lgr5-CreER and 
control mice were given 3 consecutive doses of Tamoxifen, 24 hours apart, and were exposed to 
12 Gy γ-IR three days after the last dose. Tissue was harvested 3 days after γ-IR. H&E stained 
sections from the jejunum were used for quantification of regeneration efficiency (regenerative 
crypt foci per unit length of small intestine) (n=4-6). Scale bar=100μM 
All data are expressed as mean +/- s.d. (* p<0.05, **p<0.005, ***p<0.0005, Student’s t test). 
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Figure 4. 5. Msi loss does not affect intestinal differentiation following radiation injury 
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Figure 4.5. Msi loss does not affect intestinal differentiation following radiation injury 
(A) Representative hematoxylin and eosin (H&E) stained sections from jejunum of irradiated 
Msi1flox/flox::Villin-CreER, Msi2flox/flox::Villin-CreER, Msi1/2flox/flox::Villin-CreER, and control 
mice. All groups of mice were given 5 daily consecutive doses of Tamoxifen and were 
exposed to 12Gy γ-IR one week later. Tissue was harvested 3 days after γ-IR (n=5-6). 
Scale bar=100μM 
(B) Lysozyme staining of sections from jejunum of mice described above. Scale bar=100 μm 
(C) Alcian blue staining of sections from jejunum of mice described above. Scale bar=100 μm 
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Figure 4. 6. Msi is upregulated during activation of reserve ISCs and is required for lineage 
tracing from these cells under basal conditions 
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Figure 4.6. Msi is upregulated during activation of reserve ISCs and is required for lineage 
tracing from these cells under basal conditions 
(A) Representative immunofluorescence micrographs of Hopx-CreER reserve ISCs and their 
progeny in Hopx-CreER::LSL-tdTomato mice 18 hours (top) and 4 days (bottom) after a single 
Tamoxifen injection. TdTomato (red), E-Cadherin (white), and DAPI (blue). Scale bar=50 μM. 
(B) Violin plots showing expression levels of Msi1, Msi2, Lgr5, Ascl2, Cdkn1a, and Ccnd1 in 
single, FACS-purified Bmi1- and Hopx-CreER ISCs, their daughter cells (progeny), and Lgr5-
eGFP+ CBCs. Bmi1- and Hopx-CreER+ ISCs were marked by a single dose of Tamoxifen in 
Bmi1- or Hopx-CreER::LSL-tdTomato mice and were purified by FACS 18 hours later. Hopx-
CreER progeny were isolated by FACS purification of tdTomato+ cells 96 hours after activation of 
the tdTomato reporter. The width of the violin plot represents the number of single cells at the 
given expression level on the y-axis. The white dot within the violin plot represents the mean 
expression value for the group of cells. 
(C) Immunofluorescence staining for tdTomato (red) and E-Cadherin (white) and quantification of 
lineage tracing events (ribbons of tdTomato+ cells with contiguous tracing from crypts, through 
crypt-villus junction, and into villi) from Bmi1- and Hopx-CreER ISCs 14 days after marking 
reserve ISCs with a single Tamoxifen injection to Hopx-CreER::LSL-tdTomato::Msi1/2flox/flox  or 
Bmi1-CreER::LSL-tdTomato::Msi1/2flox/flox mice and their control counterparts (n=3, scale 
bar=50μM).  Arrowheads point to single MsiDKO cells that are not able to contribute in lineage 
tracing.  
All data are expressed as mean +/- s.d. (* p<0.05, ***p<0.0005, Student’s t test). 
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Figure 4. 7. Msi is upregulated following radiation injury coupled with exit of reserve ISCs 
from quiescence into cell cycle 
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Figure 4.7. Msi is upregulated following radiation injury coupled with exit of reserve ISCs 
from quiescence into cell cycle 
(A) Analysis of cell cycle distribution of different reserve ISC populations using Pyronin Y and 
DAPI staining in Bmi1-CreER::LSL-tdTomato and Hopx-CreER::LSL-tdTomato mice, 18 hours 
after Tamoxifen injection. Cell cycle distribution was determined using Pyronin Y and DAPI 
staining during homeostasis. Pyronin Ylow DAPIlow (2n) cells: G0; Pyronin Yhigh DAPIlow (2n) cells: 
G1; and Pyronin Yhigh DAPIhigh cells (>2n DNA content): G2/M, (n=3). 
(B) Analysis of quiescence in Hopx-CreER+ ISCs using Pyronin Y and DAPI staining under basal 
conditions and 24 hours after 12Gy γ-IR. To mark Hopx-CreER ISCs, mice were injected with 
Tamoxifen 18 hours before harvest (n=4-5). 
(C) Immunofluorescence staining for Msi1 and quantification of Msi1 fluorescence intensity in 
Hopx-CreER+ ISCs, 48 hours after irradiation and 18 hours after Tamoxifen induction. Shown are 
micrographs of individual FACS-purified ISCs (n=3, scale bar=5 μM). 
(D) Analysis of cell cycle distribution of FACS-purified tdTomato+ cells from Hopx-CreER::LSL-
tdTomato::Msi1/2flox/flox or control mice 3 days after the second of two daily consecutive Tamoxifen 
doses given during homeostasis (n=3-4). 
(E) EdU stained sections from the jejunum of Msi1/2flox/flox::LSL-tdTomato::Hopx-CreER and 
control mice, treated with 2 daily doses of Tamoxifen. The mice were divided to two groups and 
one group received 12 Gy γ-IR immediately after the second dose of Tamoxifen. Tissue was 
harvested 2 days after the second dose of Tamoxifen. The graph shows EdU incorporation of 
tdTomato+ 48 hours after IR in either presence or absence of Msi (n=3, Scale bar=50μM).  
All data are expressed as mean +/- s.d. (* p<0.05, **p<0.005, ***p<0.0005, Student’s t test). 
	 84	
 
 
 
 
 
 
 
 
Figure 4. 8. Msi is upregulated in regenerative 
crypt foci following radiation injury 
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Figure 4.8. Msi is upregulated in regenerative crypt foci following radiation injury 
(A) Sections from the jejunum of small intestine of wildtype mice, 4 days after exposure to 
12Gy γ-IR, stained for Ki67, Msi1 and Msi2. Scale bar =25μM. 
(B) Immunofluorescence staining of Msi1 at the indicated timepoints after 12Gy γ-IR. Scale 
bar=50 μm 
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Figure 4. 9. Msi upregulation is sufficient to activate metabolic genes in reserve ISCs and 
drive these cells out of quiescence into cell cycle 
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Figure 4.9. Msi upregulation is sufficient to activate metabolic genes in reserve ISCs and 
drive these cells out of quiescence into cell cycle 
(A) Analysis of cell cycle distribution of Bmi1-CreER ISCs 36 hours after induction of Msi1 
expression in TRE-Msi1::Bmi1-CreER::tdTomato and Bmi1-CreER::tdTomato control mice. Both 
TRE-Msi1 and control (R26-m2rtTA) groups were treated with doxycycline in their drinking water 
for 18 hours then given 1 dose of Tamoxifen and maintained on dox for an additional 18 hours 
before tissue harvest (n=4). 
(B) Assessment of EdU incorporation in Hopx-CreER ISCs from doxycycline and Tamoxifen 
treated TRE-Msi1::Hopx-CreER::tdTomato and control (R26-m2rtTA +dox) mice as described in 
(A) (n=4-5).  
(C) Quantification of frequency of Hopx- and Bmi1-CreER+ ISCs from doxycycline- (total 36 
hours) and Tamoxifen- (18 hours before tissue harvest) treated TRE-Msi1::Hopx-
CreER::tdTomato, TRE-Msi1::Bmi1-CreER::tdTomato, and control (R26-m2rtTA +dox) mice (n=3-
4). 
(D) Lineage tracing from Hopx-CreER ISCs staining for tdTomato in sections from Tre-
Msi1::Hopx-CreER::tdTomato and control (R26-m2rtTA +dox) mice 48 hours after doxycycline 
and Tamoxifen treatment (Scale bar =50μM). 
(E) Violin plots showing the expression level in populations of single ISCs.  The white dot in the 
violin plot represents the median expression within the group of cells, the black box represents 
the interquartile range, and the width of the plot is directly correlated to the number of cells at the 
given expression level indicated on the y-axis. 
(F) Principal component analysis of cellular identity in single Lgr5-eGFPHigh CBCs and quiescent 
(Bmi1-CreER+) ISCs with and without Msi1 induction based on the expression profiling of 48 
transcripts representing the Wnt pathway, Notch pathway, proliferation, metabolism, and stem 
cell identity. Each sphere represents a single cell, and the percent of variation ascribed to each of 
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the principle components is delineated on the axes. The cages around the Bmi1-CreER (red) and 
Lgr5-eGFP (green) populations represent the domain contained within 2 standard deviations of 
the arithmetic centroid of the population. Color-coding of ISCs is indicated in panel. All data are 
expressed as mean +/- s.d. (*p<0.05, **p<0.005, ***p<0.0005, Student’s t test). 
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Figure 4. 10. Forced expression of Msi1 activates metabolic genes in reserve ISCs 
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Figure 4.10. Forced expression of Msi1 activates metabolic genes in reserve ISCs 
(A) Heatmap showing Fluidigm Biomark profiling of Lgr5-eGFPHigh CBCs and Bmi1-CreER+ 
ISCs, both in the absence (control) and presence of Msi1 induction. Every column 
contains a single cell, and every row a single primer pair, with two distinct primer sets 
being used to interrogate each of the transcripts listed on the right. Colors correspond 
directly to Ct value, black being >30 (no detectable transcript).  
(B) Quantification of regeneration based on H&E stained sections from the jejunum of 
irradiated TRE-Msi1 and control (R26-m2rtTA) mice. Both groups received doxycycline 
for 24 hours starting 48 hours after irradiation and were harvested three days after γ-IR. 
Quantification of regeneration efficiency was done by counting regenerative crypt foci, 
defined as 10 or more adjacent chromophilic cells and a lumen in H&E stained sections 
(n=6). 
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 Figure 4. 11. mTORC1 activation is sufficient to rescue the impaired regeneration in 
MsiDKO mice after high-dose irradiation 
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Figure 4.11. mTORC1 activation is sufficient to rescue the impaired regeneration in 
MsiDKO mice after high-dose irradiation. 
(A) Western blot analysis of phosphorylation of S6 as a proxy readout for mTORC1 activity, 
in ISC population 36 hours after induction of Msi1 expression in TRE-Msi1::Bmi1-
CreER::tdTomato and TRE-Msi1::Hopx-CreER::tdTomato and control mice. Both TRE-
Msi1 and control groups were treated with doxycycline for 36 hours and 1 dose of 
Tamoxifen 18 hours before tissue harvest. 
(B) Clip-qPCR assessing Msi1 binding to Pten mRNA in FACS-sorted Hopx-CreER ISCs. 
Both TRE-Msi1 and rtTA (control) groups were treated with doxycycline for 36 hours and 
were given 1 dose of Tamoxifen to activate fluorescent marker 18 hours before tissue 
harvest. 
(C) Immunofluorescence staining for PIP3 and quantification of PIP3 fluorescence intensity in 
Hopx-CreER+ ISCs, 48 hours after irradiation and 18 hours after Tamoxifen induction. 
Control mice did not receive irradiation (n=2, scale bar=5 μM). 
(D) Quantification of the regeneration efficiency after irradiation injury in mice receiving 1.5% 
Leucine in their drinking water 1.5 days after γ-IR and in control groups (n=3). 
(E) Immunostaining for Ki67 and pS6 on sections from jejunum of control, Msi-DKO and 
Leucine-treated Msi-DKO mice 3 days following 12 Gy γ-IR (Scale bar=25μM) and 
Quantification of regeneration efficiency of Msi1/2flox/flox::Villin-CreER  and control mice 
following 12 Gy γ-IR. All groups received 5 consecutive doses of Tamoxifen and were 
irradiated one week after the last dose. 1.5% Leucine was given to + Leu groups 36 
hours after γ-IR and tissue was harvested 3 days after γ-IR (n=8-9). 
All data are expressed as mean +/- s.d. (* p<0.05, **p<0.005, ***p<0.0005, Student’s t 
test). 
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Figure 4. 12. Msi activity regulates radiosensitivity of intestinal epithelium 
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Figure 4.12. Msi activity regulates radiosensitivity of intestinal epithelium  
(A) H&E stained sections from the jejunum of irradiated TRE-Msi1 and control (R26-m2rtTA) 
mice. Both groups received doxycycline for 24 hours before irradiation and were harvested three 
days after γ-IR. During regeneration period mice received regular drinking water (no doxycycline). 
Quantification of regeneration efficiency following irradiation injury was done by counting 
regenerative crypt foci, defined as 10 or more adjacent chromophilic cells and a lumen in H&E 
stained sections (n=3-4). 
(B) Model depicting behavior of reserve and active ISCs during homeostasis and regeneration 
following high-dose γ-IR. 
All data are expressed as mean +/- s.d. (**p<0.005, Student’s t test). 
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Table 4. 1. Differentially expressed genes between MsiDKO (Villin-CreER) intestinal crypts 
and their control counterparts identified by microarray 
Gene Symbol RefSeq Fold-Change M12 p-value M12 
5730507C01Rik NM_001201330 2.66582 0.0950951 
Grb10 NM_010345 2.60178 0.0895023 
S1pr3 NM_010101 2.12768 0.0734615 
Zfp125 AJ005350 2.05704 0.0536049 
Snai2 NM_011415 1.99935 0.0720264 
Fabp6 ENSMUST00000020672 1.95362 0.00564633 
Sparcl1 NM_010097 1.91633 0.0851181 
Pcdh18 NM_130448 1.8676 0.0613742 
Rec8 ENSMUST00000002395 1.803 0.0793345 
Hbb-y ENSMUST00000033229 1.78254 0.0754809 
Emcn ENSMUST00000122064 1.77835 0.0906314 
Tbx5 NM_011537 1.77116 0.0984079 
Lix1l NM_001163170 1.75491 0.0376084 
Mmp2 NM_008610 1.75071 0.0532351 
Pdgfra NM_001083316 1.73018 0.0845211 
1700024P16Rik NM_001162980 1.71295 0.0138972 
AF357355 NR_028433 1.66275 0.0769029 
Gja1 NM_010288 1.63186 0.084757 
Nrk NM_013724 1.63038 0.0761408 
Suox NM_173733 1.63002 0.0971738 
Fbn2 NM_010181 1.62848 0.0739999 
Msn NM_010833 1.6232 0.0482963 
Nid1 NM_010917 1.61724 0.0476806 
Epha7 NM_010141 1.60837 0.0980257 
Slc25a4 ENSMUST00000034049 1.60303 0.0204463 
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AF357426 NR_046303 1.60253 0.0767984 
Ddr2 NM_022563 1.59813 0.0159469 
Hsd3b6 NM_013821 1.58659 0.0539781 
Rgs5 ENSMUST00000027997 1.58512 0.0345155 
Rcn3 NM_026555 1.5845 0.0108554 
Rdx NM_009041 1.58402 0.050361 
Gucy1a3 NM_021896 1.57178 0.0410353 
Gm14475 ENSMUST00000170569 1.55118 0.0360287 
Gsta3 NM_001077353 1.53199 0.0310757 
Robo1 NM_019413 1.52015 0.0798538 
Actg1 NM_009609 -1.52 0.00633933 
Gbp7 NM_145545 -1.54424 0.0957129 
Iigp1 NM_001146275 -1.65319 0.0988337 
ND6 ENSMUST00000082419 -1.69169 0.0197823 
Tnfrsf23 NM_024290 -1.69404 0.0828604 
Gm12250 NM_001135115 -1.8136 0.0948251 
Gm3219 NR_027380 -1.88489 0.0345574 
Gdpd3 NM_024228 -1.99316 0.0652661 
Pnp2 ENSMUST00000095925 -2.81279 0.0386482 
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Summary and Conclusions 
 I have shown that calorie restriction increases the number of reserve stem cells and 
enhances the regenerative capacity of the intestinal epithelium. Ablation of reserve intestinal stem 
cells (ISCs) disrupts the enhanced tissue regenerative response of calorie-restricted mice 
following radiation injury. RNA-sequencing and histological analysis showed that mTORC1 
signaling is downregulated in reserve ISCs in response to calorie restriction but calorie-restricted 
mice maintained an enhanced capacity to activate mTORC1 signaling following radiation injury. 
Downregulation of mTORC1 signaling utilizing mouse genetic approaches or Rapamycin 
decreases lineage tracing from reserve ISCs under basal conditions and proved to be protective 
of the reserve ISCs against radiation injury. However, if mTORC1 signaling is inhibited during the 
regeneration phase after injury, regenerative potential of the intestinal epithelium is strongly 
impaired. These findings support a model where low mTORC1 activity in reserve ISCs confers 
resistance to DNA damaging injury, while a robust ability to activate mTORC1 in these cells after 
DNA damaging injury is required for an efficient regenerative response. 
The Musashi (Msi) family of RNA-binding proteins, which are expressed in the intestinal 
crypts and act as upstream activators of mTORC1 signaling in mouse models of colorectal cancer 
(Li et al., 2015; Wang et al., 2015), are dispensable for intestinal homeostasis. Consistently, loss 
of Msi does not affect frequency, proliferation, or stem cell capacity of actively cycling crypt base 
columnar cells (CBCs). Msi is upregulated during regeneration and its upregulation is sufficient to 
activate mTORC1 signaling and metabolic genes specifically in reserve ISCs. This results in the 
exit of reserve ISCs from quiescence and entry into the cell cycle. Conversely, Msi loss abrogates 
the ability of reserve ISCs to properly enter the cell-cycle, decreases lineage tracing events from 
reserve ISCs under basal conditions, and impairs the regeneration capacity of the intestinal 
epithelium following injury. Activity of the Msi-mTORC1 axis is absolutely required during the 
regeneration following DNA damaging injury, and, remarkably, stimulation of mTORC1 activity 
using Leucine can rescue the impaired regeneration in the absence of Msi. These results have 
implications for several fields of research, which I outline below. 
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Calorie restriction increases stem cell availability and regeneration efficiency 
Long-term calorie restriction (CR) preserves the function of stem cells during aging and in  
some cases delays onset of age-related diseases, leading to longer life span (Lee et al., 2010; 
Mair and Dillin, 2008).  Prior studies in the hematopoietic system suggested that lifelong calorie 
restriction preserves stem cell function, which normally declines with age (Ertl et al., 2008). Short-
term calorie restriction in young and healthy animals can enhance the regenerative response 
following injury. However, the specific cell type responsible for this enhanced regenerative 
capacity and as a result, the molecular determinants of this process are poorly understood. 
Cerletti et al showed that short-term calorie restriction, on both young and aged animals, 
leads to increase in frequency and in vitro myogenic capacity of satellite cells, a population 
of self-renewing skeletal muscle stem cells. The regenerative capacity of muscles after injury, is 
increased in calorie restricted mice, and calorie restricted satellite cells produce twice as many 
fibers as satellite cells from a freely fed mouse upon transplantation into a mouse model of 
Duchenne muscular dystrophy (Cerletti et al., 2012). Similarly, short-term calorie restriction 
prevents the age-related decline in frequency and reconstitution capacity of HSCs following 
transplantation (Chen et al., 2003). However, the extent of contribution of calorie-restricted stem 
cells to the increase in regenerative capacity and the response of these cells to injury in their 
native environment remain unknown.  
In the intestinal epithelium, calorie restriction slightly increases the frequency of actively 
cycling CBCs and their in vitro organoid formation capacity. Calorie restriction instructs actively 
cycling CBCs through nutrient sensing and secretion of signaling molecules by their surrounding 
Paneth cells (Igarashi and Guarente, 2016; Yilmaz et al., 2012). Yilmaz et al. demonstrated an 
enhanced regenerative capacity of the intestinal epithelium after exposure to ionizing radiation in 
calorie-restricted mice (Yilmaz et al., 2012). However, whether this enhanced regeneration is a 
result of an increase in the frequency or function of actively cycling CBCs (which are highly 
sensitive to DNA damage), or whether Paneth cells are crucial in the enhanced regenerative 
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response following radiation injury in unclear. This is evident in experiments in which Paneth cells 
are genetically ablated and the tissue is subjected to radiation injury.  These experiments suggest 
that the absence of Paneth cells does not negatively influence the regenerative response.  Thus, 
the cellular basis for the enhanced regenerative response of the calorie restricted intestinal 
epithelium remains unknown. 
My work demonstrated that calorie restriction increases the frequency of reserve 
intestinal stem cells, which are crucial for proper intestinal regeneration. To demonstrate the 
functional contribution of the reserve ISCs in regeneration following radiation injury, I ablated 
these cells using diphtheria toxin after a period of calorie restriction and showed that the reserve 
ISC ablation leads to about 40% reduction in the enhanced tissue regenerative capacity of calorie 
restricted mice. This piece of data clearly demonstrates that reserve intestinal stem cells respond 
to nutrient cues and play a major role in the enhanced regenerative capacity of the tissue after 
calorie restriction.  However, the tissue regenerative capacity of calorie restricted mice in the 
absence of reserve ISCs was not fully reduced to regenerative capacity of freely fed control mice. 
This could be a result of inefficiency of our system in ablating reserve ISCs or the presence of 
other cell types playing a role in tissue regeneration. It is not clear whether actively cycling CBCs, 
which are highly radiosensitive, or Paneth cells, which are not required for intestinal regeneration 
following IR in freely fed mice, play different roles after calorie restriction and could possibly be 
crucial for the CR-induced enhanced tissue regeneration capacity. My findings provide the first 
evidence that reserve stem cells are functionally important for the enhanced regenerative 
response to injury in calorie restricted animals. 
The studies mentioned above demonstrate that stem cells of different tissues are capable 
of responding to the metabolic state in the body, and nutrient intake can regulate their 
regenerative capacity in response to injury or upon transplantation. Answers to the questions 
surrounding the effect of calorie restriction on the response of tissue stem cells upon exposure to 
injury and understanding the functional contribution of specific cell types to the enhanced 
regenerative capacity in calorie restricted animals may help to improve the targeting and 
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transplantation of stem cells for therapy and illuminate metabolic regulators of tissue stem cell 
function. 
My study and others show that mTORC1 signaling is inhibited in reserve  ISCs and long-
term HSCs in response to calorie restriction (Harrison et al., 2009; Yousefi et al., 2017). 
Hyperactivation of mTORC1 signaling leads to hyperproliferation and depletion of neural stem 
cells and HSCs (Groszer, 2001, 2001; Kalaitzidis et al., 2012; Yilmaz et al., 2006).  Here, I show 
that downregulation of mTORC1 signaling in response to calorie restriction or Rapamycin 
treatment protects the reserve ISCs against radiation injury, and, conversely, mTORC1 
stimulation with Leucine sensitizes the tissue to radiation injury (Yousefi et al., 2017).  
Msi RNA binding proteins acts as upstream activators of mTORC1 in reserve intestinal 
stem cells under basal conditions and during oncogenic transformation(Li et al., 2015; Wang et 
al., 2015; Yousefi et al., 2016). However, it is not clear whether Msi regulates mTORC1 activity in 
reserve ISCs in response to calorie restriction as well.  A clear understanding of a crosstalk 
between nutrient availability, Msi regulation, and modulation of mTORC1 signaling could provide 
novel targets for therapeutic intervention to protect patients against acute side effects of DNA 
damage associated with clinically relevant injuries such as radiation therapy, chemotherapy, 
ischemia-reperfusion, or chronic inflammation, with the ultimate goal of enhancing tissue 
regeneration and preventing oncogenesis. 
 
An Msi-mTORC1 axis regulates activation of reserve stem cells 
In most of the mammalian tissues, stem cells are responsible for proliferation and 
compensation for cell loss occurring during the normal tissue turnover or upon injury (Weissman, 
2000). A fraction of stem cells resides in quiescence (G0), which is defined as a non-cycling state 
with the ability to enter cell cycle in response to normal physiological stimuli. Besides the cell 
cycle state, quiescent cells are believed to have low levels of global transcription and metabolic 
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activity, while retaining the ability to upregulate both processes upon receiving physiological 
stimuli (Cheung and Rando, 2013; Fukada et al., 2007; Hüttmann et al., 2001).  
My study and others demonstrate that the majority of reserve ISCs (>60%) and LT-HSCs 
(≈90%) reside in G0. Interestingly, smaller fractions of populations of active stem cells in the 
intestinal epithelium and hematopoietic system (CBCs and ST-HSCs) are quiescent, and these 
cells also have shorter life-spans compared to their reserve ISC and LT-HSC compartments (Li et 
al., 2014, 2016b; Pietras et al., 2011; Yousefi et al., 2016). Consistently, dysregulation of 
quiescence could lead to depletion of stem cell populations due to inappropriate stem cell 
activation and production of downstream progenitor cells and as a result, this can impair tissue 
regeneration (Li and Clevers, 2010; Orford and Scadden, 2008). These observations imply a 
functional role for quiescence in preserving the tissue stem cell pool throughout the adult life by 
precisely regulating cell cycle entry and commitment to downstream cell types. However, whether 
quiescence and stem cell dormancy have varying roles under basal conditions, in response to 
injury, during regeneration, or in response to oncogenic transformation is poorly understood. 
While the molecular underpinnings of stem cell quiescence have been extensively studied in the 
HSCs and satellite cells of skeletal muscle (Kalaitzidis et al., 2012; Rodgers et al., 2014), very 
little is known about this phenomenon in intestinal stem cells. Answers to these questions may 
lead to new therapeutic strategies for preventing tissue damage, malignant transformation, and 
enhancing regenerative responses to injury. 
Here, I show that activity of the Msi-mTORC1 axis is not required for intestinal 
homeostasis under basal conditions but absolutely essential during regeneration in response to 
radiation injury. The differential requirement for molecular pathways important for tissue 
maintenance versus those required in response to injury or oncogenic transformation is 
substantiated with an increasing body of literature (Biteau et al., 2011). My study and others 
demonstrate that the Msi-mTORC1 signaling axis is activated during regeneration after injury, as 
well as, in Apcmin mouse model of colorectal cancer. Loss of Msi or inhibition of mTORC1 
signaling abrogates the regenerative response following damage and decreases the tumor 
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burden in Apcmin mouse model of colorectal cancer (Ashton et al., 2010; Faller et al., 2015; Li et 
al., 2015; Wang et al., 2015; Yousefi et al., 2016, 2017).  
My work delineates a requirement for the activity of the Msi-mTORC1 axis in the rare 
population of reserve ISCs. In these cells, the Msi-mTORC1 is inactive in quiescent stem cells 
residing in G0, and activation of Msi-mTORC1 is sufficient to drive quiescent stem cells out of G0 
and into cell cycle. Conversely, inactivation of this pathway leads to a G1 block in reserve ISCs 
(Yousefi et al., 2016). Interestingly, a nearly identical phenomenon is observed in LT-HSCs, 
where Msi2 is both necessary and sufficient for their proper exit from quiescence and cell cycle 
entry (Kharas et al., 2010; Park et al., 2014). The importance of this mechanism for tissue fidelity 
can be observed in the intestinal epithelium in the context of injury. I observed that premature 
upregulation of Msi-mTORC1 signaling drives reserve ISCs out of quiescence. If the tissue is 
then exposed to DNA damaging injury, these reserve ISCs now become sensitized to DNA 
damage, undergo cell death, and are no longer able to regenerate the tissue effectively. Thus, 
these findings show that besides the established effect of dysregulation of quiescence on stem 
cell exhaustion (Orford and Scadden, 2008), precise regulation of this process is also a 
determinant of a tissue’s response to injury. 
 
Future directions: mimicking calorie restriction, accelerating a cure for cancer, and 
reducing side effects of therapeutic approaches 
Highly proliferative tissues provide a powerful platform to study adult stem cell behavior 
under basal, tumorigenic, and regenerative conditions. Injury (specifically DNA damage) to the 
intestinal epithelium is a hallmark of numerous common clinical disorders, including radiation 
enteropathy, chemotherapy, ischemia-reperfusion, and inflammatory bowel diseases.  Disruption 
of the epithelial barrier in these conditions must be quickly restored to avoid dehydration and 
translocation of gut microbiota to the bloodstream.  My results provide compelling evidence for 
nutrient sensing in regulation of intestinal stem cell resistance to radiation injury and 
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subsequently, the tissue’s regeneration capacity. Further work is required to address whether the 
paradigm we established using radiation injury hold true in other injury models (e.g. 
chemotherapy, ischemia-reperfusion, and inflammation). It will also be critical to understand how 
nutrient modulation might affect tumor cells at the molecular level, since damage to highly 
proliferative tissues such as intestinal epithelium is one of the main side effects of cancer 
treatments by chemotherapy and radiotherapy with the aim of ablating tumor cells. For example, 
might the beneficial effects of calorie restriction on regeneration of the normal epithelium after 
chemo/radiation therapy also have unintended protective consequences for tumor initiating cells? 
Calorie restriction regulates processes involved in cancer initiation and progression such 
as apoptosis, proliferation, angiogenesis, inflammation, hormone, and growth factor production. In 
addition, signaling pathways that are targeted in cancer treatment often overlap with those 
regulated by calorie restriction, such as Akt-mTORC1 signaling. These observations have led to 
investigations into CR as a potential treatment for cancer. In animal models, calorie restriction 
prevents tumor formation, progression, and metastasis (De Lorenzo et al., 2011; Michels and 
Ekbom, 2004; Phoenix et al., 2010).  Rapamycin, a potent inhibitor of mTORC1 signaling, can 
also decrease the incidence, growth, and metastasis of cancer cells (Anisimov et al., 2011; Boffa 
et al., 2004; Guba et al., 2002). 
Relative independence of cancer cells from external growth and anti-growth signals 
prevents their proper response to environmental cues (Hanahan and Weinberg, 2011; Lee et al., 
2012). In vitro studies of cells in the culture have shown that activation of the Akt-mTORC1 
signaling pathway, one of the highly upregulated signaling pathways in many tumor types, 
promotes oxidative stress and sensitizes the cells to oxidative damage partly through inhibition of 
FoxO transcription factors, which have a conserved role in regulation of detoxifying enzymes 
(Greer and Brunet, 2005; Nogueira et al., 2008). Following fasting, increased levels of Akt and S6 
kinase phosphorylation in cancer cells relative to normal cells sensitize cancer cells to 
chemotherapeutic agents while protecting the normal cells (Lee et al., 2012; Raffaghello et al., 
2008). Consistently, fasting prior to and/or following chemotherapy led to a reduction in fatigue, 
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weakness, and gastrointestinal side effects in patients with various malignancies including breast, 
esophageal, prostate, and lung cancers (Raffaghello et al., 2010; Safdie et al., 2009). Calorie 
restriction could also synergize with radiotherapy to increase the apoptosis of breast cancer cells 
(Saleh et al., 2013). These results suggest that a nutritional intervention not only can affect tumor 
initiation, progression, and metastasis, but it can also have additive effects when combined with 
radiation or chemotherapy.  
 Further investigation will be required to understand the molecular mechanisms underlying 
the differential effects of nutrient modulation on normal and cancerous tissues, and specifically 
tumor initiating and normal stem cells, which are the drivers of cancer and tissue regeneration 
following cancer treatments such as radiotherapy and chemotherapy. Dietary intervention might 
not be an optimal choice for cancer patients because of the weight loss associated with cachexia 
or the side effects of radiation/chemo-therapeutic approaches. However, my work shows that 
presence of a single amino acid, Leucine, in drinking water prior to the time of radiation can 
sensitize reserve intestinal stem cells to injury and lead to poor regenerative outcome. This 
demonstrates the powerful effect nutrient modulation can have on sensitization and recovery of a 
tissue from injury, and provides strong impetus for further understanding of these effects in 
humans. Understanding the detailed molecular mechanisms underlying the effects of nutrients on 
stem and tumor initiating cells may help to target desired pathways involved in tumorigenesis and 
regeneration using customized diets or small molecules. This may accelerate the development of 
therapeutic approaches to prevent or cure malignant transformation and tissue damage in 
patients.  
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